<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1127949</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1127949</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Research progress of functional motifs based on growth factors in cartilage tissue engineering: A review</article-title>
<alt-title alt-title-type="left-running-head">Qin et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1127949">10.3389/fbioe.2023.1127949</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Shengao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Jiaman</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Guangyong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sui</surname>
<given-names>Qijia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niu</surname>
<given-names>Yimeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ye</surname>
<given-names>Weilong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2153397/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ma</surname>
<given-names>Guowu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Huiying</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/891322/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Stomatology</institution>, <institution>Dalian Medical University</institution>, <addr-line>Dalian</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Academician Laboratory of Immune and Oral Development and Regeneration</institution>, <institution>Dalian Medical University</institution>, <addr-line>Dalian</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction</institution>, <institution>Beijing Stomatological Hospital</institution>, <institution>School of Stomatology</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Stomatology</institution>, <institution>Beijing Friendship Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/489389/overview">Jianxun Ding</ext-link>, Changchun Institute of Applied Chemistry (CAS), China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/768226/overview">Sheng Zhou</ext-link>, Nanjing Drum Tower Hospital, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/120622/overview">Xufeng Dong</ext-link>, Dalian University of Technology, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2148443/overview">Wei Yin</ext-link>, Wuhan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/774563/overview">Yourong Chen</ext-link>, Peking University Third Hospital, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Weilong Ye, <email>yqw83268910@126.com</email>; Guowu Ma, <email>mgw640242000@aliyun.com</email>; Huiying Liu, <email>lhy04512000@dmu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1127949</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Qin, Zhu, Zhang, Sui, Niu, Ye, Ma and Liu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Qin, Zhu, Zhang, Sui, Niu, Ye, Ma and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Osteoarthritis is a chronic degenerative joint disease that exerts significant impacts on personal life quality, and cartilage tissue engineering is a practical treatment in clinical. Various growth factors are involved in cartilage regeneration and play important roles therein, which is the focus of current cartilage repair strategy. To compensate for the purification difficulty, high cost, poor metabolic stability, and circulating dilution of natural growth factors, the concept of functional motifs (also known as mimetic peptides) from original growth factor was introduced in recent studies. Here, we reviewed the selection mechanisms, biological functions, carrier scaffolds, and modification methods of growth factor-related functional motifs, and evaluated the repair performance in cartilage tissue engineering. Finally, the prospects of functional motifs in researches and clinical application were discussed.</p>
</abstract>
<kwd-group>
<kwd>cartilage tissue engineering</kwd>
<kwd>growth factors</kwd>
<kwd>functional motifs</kwd>
<kwd>mimetic peptides</kwd>
<kwd>chondrogenesis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Various growth factors participate in the treatment of systemic diseases. Fibroblast growth factor-2 (FGF2) (<xref ref-type="bibr" rid="B11">Beenken and Mohammadi, 2009</xref>), transforming growth factor-&#x3b2; (TGF-&#x3b2;) (<xref ref-type="bibr" rid="B75">Maeda et al., 2013</xref>) and platelet-derived growth factor (PDGF) (<xref ref-type="bibr" rid="B7">Andrae et al., 2008</xref>) were reported to play key roles in the repair of periodontal defects. In addition, FGF2 does favor to repair skin wounds (<xref ref-type="bibr" rid="B19">Chan et al., 2017</xref>) and tracheal defects (<xref ref-type="bibr" rid="B59">Kitamura et al., 2011</xref>), promotes ligament regeneration (<xref ref-type="bibr" rid="B58">Kimura et al., 2008</xref>), and treats myocardial infarction (<xref ref-type="bibr" rid="B49">Itoh and Ornitz, 2011</xref>). Hematopoietic growth factor (HGF) was administrated in liver tissue regeneration and treatment of liver cirrhosis by binding to the c-Met receptor (<xref ref-type="bibr" rid="B37">Funakoshi and Nakamura, 2003</xref>). Applications of vascular endothelial growth factor (VEGF) (<xref ref-type="bibr" rid="B48">Hanft et al., 2008</xref>) and PDGF (<xref ref-type="bibr" rid="B84">Mulder et al., 2009</xref>) in the treatment of diabetic foot ulcers exhibited good clinical prospects, and ocular anti-VEGF for age-related macular changes showed significant advance in modern medicine (<xref ref-type="bibr" rid="B23">Cheung et al., 2014</xref>). In summary, various growth factors play active therapeutic roles in modern medicines and tissue engineering.</p>
<p>Chondral defects are important causes of osteoarthritis (OA) and joint disability in the elderly, and tissue engineering has been widely studied as a promising strategy (<xref ref-type="bibr" rid="B128">Williams et al., 2005</xref>). The three elements of cartilage tissue engineering are seed cells that initiate tissue reconstruction, biological scaffolds that provide support and guidance, and growth factors that induce chondrogenic differentiation of seed cells and cartilage matrix secretion. However, hyaluronic cartilage shows little potential for self-repair owing to lack of blood supply (<xref ref-type="bibr" rid="B79">Mascarenhas et al., 2015</xref>). Unlike bone regeneration and inflammation repair, growth factors cannot enrich effectively at local tissue through blood circulation (<xref ref-type="bibr" rid="B50">Jakobsen et al., 2005</xref>), which seriously affects the cartilage repair efficiency. Direct application of intact proteins is limited for easy degradation and dilution, and high cost of labor and finance during purification. Therefore, functional motifs were considered as alternatives of intact proteins.</p>
<p>Functional motifs are a series of short peptides, whose sequences originate from a specific growth factor, so as to simulate biological domains in amino acid sequences or microspatial structures. For example, Pierschbacher <italic>et al.</italic> found the sequence Arg-Gly-Asp (RGD) in fibronectin that binds to integrin (<xref ref-type="bibr" rid="B91">Pierschbacher et al., 1985</xref>). Then synthesized RGD can bind to the fibronectin receptor on the cell surface and promote cell adhesion, which does favor to survival of stem cells in cartilage regeneration. Cwirla <italic>et al.</italic> screened a peptide from the human thrombopoietin (TPO) receptor and obtained a 14-peptide sequence to mimic natural TPO <italic>in vitro</italic> (<xref ref-type="bibr" rid="B29">Dower et al., 1998</xref>).</p>
<p>By mature solid-phase synthesis technology (<xref ref-type="bibr" rid="B12">Behrendt et al., 2016</xref>), short peptides with fewer amino acid units have been widely applied in chondrogenesis studies for their simple operation and high production capacity, as well as advanced purification technology. In this paper, we focused on the selection mechanism, carrier scaffold, and modification methods of functional motifs, and summarized the application of functional motifs in cartilage tissue engineering <italic>in vitro</italic> and <italic>in vivo</italic>. Finally, the application prospect of functional motifs in cartilage repair is analyzed and discussed.</p>
</sec>
<sec id="s2">
<title>2 Mechanism of functional motif screening</title>
<p>Interactions between proteins based on local domains of specific peptides. Geysen <italic>et al.</italic> proposed that short peptides containing key amino acid sequences can simulate certain bioactivity of proteins (<xref ref-type="bibr" rid="B43">Geysen et al., 1996</xref>). Banner <italic>et al.</italic> analyzed the crystal structure of human tumor necrosis factor (TNF) receptor and TNF-&#x3b2; complex, and found that only three clusters of amino acid residues acted between the ligand and its receptor, proving that only short peptides were involved in the interaction. Thus, it is possible to design functional motifs as mimetics of whole proteins (<xref ref-type="bibr" rid="B9">Banner et al., 1993</xref>). Generally, the screening mechanisms of motifs based on four concepts, as follows (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Selection mechanisms of functional motifs. <bold>(A)</bold>. Phage display technology. <bold>(B)</bold>. Highly repetitive conserved sequences. <bold>(C)</bold>. Microarray chip. <bold>(D)</bold>. Microstructure simulation of functional domain.</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g001.tif"/>
</fig>
<sec id="s2-1">
<title>2.1 Phage display technology</title>
<p>Phage display technology relies on a peptide library to acquire functional motifs. An exogenous gene coding a short peptide was inserted into side chain gene of shell protein of a filamentous phage III (<italic>p</italic> III) or IV. A fusion protein attached to N-terminal of (<italic>p</italic> III) or IV that expressed on the shell surface of phages. Thus, specific lengths of phage aggregation of different sequences of exogenous peptides are presented, which constitute a good coverage peptide library (<xref ref-type="bibr" rid="B106">Smith and Scott, 1993</xref>). Phages were used to bind targets, and short peptides with highly affinity with targets were obtained after multiple screening. Finally, motifs were obtained by chemical synthesis.</p>
<p>In 1998, Cwirla <italic>et al.</italic> screened the phage peptide library through the human TPO receptor and obtained a 14-peptide sequence, which had similar activity with TPO <italic>in vitro</italic> (<xref ref-type="bibr" rid="B29">Dower et al., 1998</xref>). In the same year, Lowman <italic>et al.</italic> used insulin-like growth factors-binding protein (IGFBP) to obtain an insulin-like growth factors (IGF) related peptide motif. The acquired motif can bind to IGFBP and function in cartilage repair (<xref ref-type="bibr" rid="B73">Lowman et al., 1998</xref>). Subsequently, Ballinger <italic>et al.</italic> screened polypeptide C-19, which can mimic binding of basic fibroblast growth factor (bFGF) to the receptor and showed the same activity as FGF (<xref ref-type="bibr" rid="B8">Ballinger et al., 1999</xref>). Koishi <italic>et al.</italic> discovered a peptide sequence, HSNGLPL, with binding affinity to TGF-&#x3b2;1, indicating important influence on the formation of connective tissue (<xref ref-type="bibr" rid="B80">McLennan and Koishi, 2004</xref>). Gelain <italic>et al.</italic> screened PFSSTKT and SKPPGTSS, functional short peptides derived from bone marrow homing peptides (BMHP), to recruit stem cell for knee cartilage repair (<xref ref-type="bibr" rid="B41">Gelain et al., 2006</xref>). Akkiraju <italic>et al.</italic> screened and synthesized bone morphogenetic protein (BMP) functional motifs CK2.1 (Syed), CK2.2 (SLYD), and CK2.3 (SLKD). CK2.1 was the most promising peptide that induces chondrogenesis rather than osteogenesis (<xref ref-type="bibr" rid="B1">Akkiraju et al., 2017a</xref>). The limits of phage display technology were high cost of time and labor in phage preparation for screening motif peptides.</p>
</sec>
<sec id="s2-2">
<title>2.2 Highly repetitive conserved sequences</title>
<p>Highly repetitive sequences might exist in some proteins. <xref ref-type="bibr" rid="B91">Pierschbacher et al. (1985)</xref> found RGD sequence in fibronectin, collagen, and thrombin, which can bind to the fibronectin receptor on the cell surface and promote cell adhesion. In addition, Gelain <italic>et al.</italic> used amino acids K, <italic>p</italic>, F, S, and T to synthesize a series of short peptides with strong affinity to stem cells, including PFSSTKT and SKPPGTSS (<xref ref-type="bibr" rid="B41">Gelain et al., 2006</xref>). <xref ref-type="bibr" rid="B127">Williams et al. (2000)</xref> found neural cadherin (N-cadherin) has an evolutionarily conserved sequence, His-Ala-Val (HAV), which provides a homophile cell adhesion domain to mediate cell-cell adhesion (<xref ref-type="bibr" rid="B16">Blaschuk et al., 1990</xref>). Williams <italic>et al.</italic> performed a series of amino acid modifications on the HAV sequence, and found that acquired peptides showed similar binding ability to N-cadherin (<xref ref-type="bibr" rid="B126">Williams et al., 2001</xref>). Bian applied HAV in cartilage tissue engineering and thereby promoted the synthesis of cartilage matrix in rats model (<xref ref-type="bibr" rid="B15">Bian et al., 2013</xref>). However, some problems remain alongside with this method. Firstly, not all peptides possess highly repetitive conserved sequences that could be recognized. Even if a series of motifs are chosen, the sequence summarization of motifs depends on the experience of researchers, and the bioactivity of motifs needs to be verified.</p>
</sec>
<sec id="s2-3">
<title>2.3 Microarray chip</title>
<p>For some proteins without highly repetitive sequences, microarray chip technology can be used to systematically screen specific sequences (<xref ref-type="bibr" rid="B35">Foong et al., 2012</xref>). In microarray chip assay, thousands of short molecules&#x2014;such as DNA, peptides, small chemical molecules, and cells&#x2014;are arrayed on a chip as receptor (<xref ref-type="bibr" rid="B109">Sun et al., 2006</xref>; <xref ref-type="bibr" rid="B118">Uttamchandani et al., 2006</xref>). Then, the entire sequence of the target protein is sequentially cut to equal lengths, and acquired peptides were administrated in the slide above. The peptides that show higher affinity to the receptor are chosen, and finally sequences are analyzed for further application. Owing to the outstanding advantages of miniaturization and parallelization, microarray chip technology has been widely used in peptide screening (<xref ref-type="bibr" rid="B26">Deng et al., 2020</xref>), antibody detection (<xref ref-type="bibr" rid="B4">Al&#x2010;Majdoub et al., 2013</xref>), and vaccine preparation (<xref ref-type="bibr" rid="B40">Gaseitsiwe et al., 2008</xref>). It should be noted that systematically screened sequences were usually short, mainly 8&#x2013;15 amino acids, with partial simulation on domain structures of original protein. Improved mimic efficiency of biological function with moderate sequence is required in further motif studies before clinical application.</p>
</sec>
<sec id="s2-4">
<title>2.4 Microstructure simulation of functional domains</title>
<p>Microstructure simulation based on analyzing the microstructure of the functional domain, and adjusting the atomic arrangement and bonding angle to simulating the spatial structure. For example, Bhatnagar directly analyzed the structure of TGF-&#x3b2;, and proposed that the &#x3b2;-turn structure is of vital significance for its bioactivity. Then, a series of short peptides containing six or seven amino acids was developed, termed as cytomodulin (CM) family (<xref ref-type="bibr" rid="B14">Bhatnagar et al., 2003</xref>). Zhang <italic>et al.</italic> combined CM10 (LIANAK) with functional nanofibrous hollow microspheres (FNF-HMS), and implated subcutaneously in the backs of mice. Finally, ectopic cartilages were realized (<xref ref-type="bibr" rid="B135">Zhang et al., 2015a</xref>). However, the structure of functional domain is not fixed on different conditions, so as to realize the expose and block of bioactivity site. Simple structural simulation may not simultaneously satisfy the microscopic requirement in activation and inactivation of motifs.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Functional motifs functions for cartilage tissue engineering</title>
<p>The <italic>in vivo</italic> and <italic>in vitro</italic> studies about growth factor-relative functional motifs are summarized as follows (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Functional motifs applications for cartilage tissue engineering.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Growth factor</th>
<th align="center">Function</th>
<th align="center">Motif sequence</th>
<th align="center">Selection mechanism</th>
<th align="center">Carrier</th>
<th align="center">Modification</th>
<th align="center">Cell/Species</th>
<th align="center">Results</th>
<th align="center">Reference</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="7" align="left">TGF-&#x3b2;</td>
<td align="center">Promote differentiation of MSCs into chondrocytes <xref ref-type="bibr" rid="B17">Blumenfeld et al. (1997</xref>)</td>
<td rowspan="2" align="left">ANVAENA (CM-1)</td>
<td rowspan="2" align="left">Microstructure simulation</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">Rat</td>
<td align="left">CM1 improved the thickness of neotissue and collagen secretion in mouse wound model</td>
<td align="left">
<xref ref-type="bibr" rid="B30">El-Sakka et al. (1997)</xref>
</td>
</tr>
<tr>
<td align="center">Improve cartilage matrix synthesis, such as collagen type&#x2161;and proteoglycans <xref ref-type="bibr" rid="B39">Garbuzenko et al. (2009</xref>)</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">hMSCs</td>
<td align="left">CM1 improved the GAGs production, independent of dosage</td>
<td align="left">
<xref ref-type="bibr" rid="B97">Renner and Liu (2013)</xref>
</td>
</tr>
<tr>
<td align="center">Reduce the activity of cytokines related to cartilage injury, such as interleukin-1 <xref ref-type="bibr" rid="B104">Sellers et al. (1997</xref>)</td>
<td rowspan="2" align="left">LIAEAK (CM-2)</td>
<td rowspan="2" align="left">Microstructure simulation</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">hMSCs</td>
<td align="left">CM2 improved the GAGs production, independent of dosage</td>
<td align="left">
<xref ref-type="bibr" rid="B97">Renner and Liu (2013)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">CX-HA</td>
<td align="center">Covalent bond</td>
<td align="center">hPLSCs</td>
<td align="left">Chemically crosslinked CM2 showed stabler release and better GAGs deposition, compared with physically mixed into HA hydrogel</td>
<td align="left">
<xref ref-type="bibr" rid="B88">Park et al. (2019)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="3" align="left">LIANAK (CM-10)</td>
<td rowspan="3" align="left">Microstructure simulation</td>
<td rowspan="2" align="center">FNF-HMS</td>
<td rowspan="2" align="center">Covalent bond</td>
<td align="center">BMSCs</td>
<td rowspan="2" align="left">Safranin O, Von kossa and immunohistochemical stains showed better deposition of GAGs and collagen, with little calcification</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B135">Zhang et al. (2015a)</xref>
</td>
</tr>
<tr>
<td align="center">Rat</td>
</tr>
<tr>
<td align="left"/>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">Rat</td>
<td align="left">CM10 induced early epithelialization and vascularization of skin wound, so as to strengthen the collagen deposition and tissue reconstruction</td>
<td align="left">
<xref ref-type="bibr" rid="B10">Basu et al. (2009)</xref>
</td>
</tr>
<tr>
<td rowspan="6" align="left">BMHP</td>
<td rowspan="6" align="left">Recruitment of MSCs to cartilage defect areas <xref ref-type="bibr" rid="B71">Liu et al. (2013</xref>)</td>
<td rowspan="3" align="left">PFSSTKT</td>
<td rowspan="3" align="left">Highly repetitive conserved sequences</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">MNSCs</td>
<td align="left">PFSSTKT recruited NSCs to local tissue, and the cell behaviors were stable, compared with Matrigel</td>
<td align="left">
<xref ref-type="bibr" rid="B41">Gelain et al. (2006)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="center">SAP hydrogel</td>
<td rowspan="2" align="center">Covalent bond</td>
<td align="center">BMSC</td>
<td align="left">RAD/PFS hydrogel did favor to the adhesion of rabbit BMSCs</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B74">Lu et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="center">Rabbit</td>
<td align="left">Better reconstruction of articular cartilage was found after implanting RAD/PFS/ACM composite scaffold into rabbit knee cartilage defect</td>
</tr>
<tr>
<td rowspan="3" align="left">SKPPGTSS</td>
<td rowspan="3" align="left">Highly repetitive conserved sequences</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">MNSCs</td>
<td align="left">SKPPGTSS recruited NSCs to local tissue, and the cell behaviors were stable, compared with Matrigel</td>
<td align="left">
<xref ref-type="bibr" rid="B41">Gelain et al. (2006)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="center">HX</td>
<td rowspan="2" align="center">Covalent bond</td>
<td align="center">BMSC</td>
<td align="left">BMSCs stayed healthy on different scaffolds</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B110">Sun et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="center">Rabbit</td>
<td align="left">RAD/SKP/PFS group showed ideal neocartilage at rabbit knee cartilage defect area</td>
</tr>
<tr>
<td rowspan="5" align="left">BMP</td>
<td align="center">Drive the development of cartilage</td>
<td rowspan="3" align="center">KIPKASSVPTELSAISTYL</td>
<td rowspan="3" align="left">Phage Display technology</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">hMSCs</td>
<td align="left">BMP-mimetic peptide significantly strengthened the secretion of GAGs in hMSCs</td>
<td align="left">
<xref ref-type="bibr" rid="B97">Renner and Liu (2013)</xref>
</td>
</tr>
<tr>
<td align="center">Induce the differentiation of mesenchymal precursor cell into chondrocytes <xref ref-type="bibr" rid="B129">Yang et al. (2011</xref>)</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">hMSCs</td>
<td align="left">BMP-mimetic peptide did favor for cartilage matrix deposition</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B96">Renner et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="center">Induce BMSCs to generate cartilage matrix both <italic>in vitro</italic> and <italic>in vivo</italic> <xref ref-type="bibr" rid="B94">Raducanu et al. (2009</xref>)</td>
<td align="left">BMP-mimetic peptide reduced the secretion of collagen type X and the ALP activity of hMSCs</td>
</tr>
<tr>
<td align="left"/>
<td rowspan="2" align="center">SYED (CK2.1)</td>
<td rowspan="2" align="left">Phage Display technology</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">Rat</td>
<td align="left">CK2.1 increased the regeneration of cartilage but decreased the expression of collagen type X and osteocalcin</td>
<td align="left">
<xref ref-type="bibr" rid="B1">Akkiraju et al. (2017a)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">HGP</td>
<td align="center">Covalent bond</td>
<td align="center">Rat</td>
<td align="left">CK2.1-HGP improved the cartilage restoration in mice but showed no evidence of hypertrophy, and lower deposition of collagen type X</td>
<td align="left">
<xref ref-type="bibr" rid="B2">Akkiraju et al. (2017b)</xref>
</td>
</tr>
<tr>
<td rowspan="7" align="left">N-Cadherin</td>
<td rowspan="7" align="left">Mediate the aggregation and condensation of progenitor cells and MSCs <xref ref-type="bibr" rid="B112">Tavella et al. (1994</xref>)</td>
<td rowspan="7" align="center">HAV</td>
<td rowspan="7" align="left">Highly repetitive conserved sequences</td>
<td rowspan="2" align="center">MeHA hydrogel</td>
<td rowspan="2" align="center">Covalent bond</td>
<td align="center">hMSCs</td>
<td rowspan="2" align="left">The productions of GAGs and collagen in HVA group were increased than other groups <italic>in vitro</italic> and <italic>in vivo</italic>
</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B15">Bian et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="center">Rat</td>
</tr>
<tr>
<td rowspan="2" align="center">E-PA</td>
<td rowspan="2" align="center">Covalent bond</td>
<td rowspan="2" align="center">hMSCs</td>
<td align="left">Cells adhered the HAV/E-PA network well</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B31">Eren Cimenci et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Cells cultured on the HAV/E-PA scaffold secreted more GAGs, and showed higher expression of chondrogenic markers</td>
</tr>
<tr>
<td rowspan="2" align="center">KLD hydrogel</td>
<td rowspan="2" align="center">Covalent bond</td>
<td rowspan="2" align="center">hMSCs</td>
<td align="left">With stimulation of HAVDI, the secretion of GAGs and gene expression of chondrogenesis were upgraded</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B67">Li et al. (2017a)</xref>
</td>
</tr>
<tr>
<td align="left">The subcellular localization changed</td>
</tr>
<tr>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">hMSCs</td>
<td align="left">HAV strengthened the expressions of early chondrogenic markers, depending on the dosage strongly</td>
<td align="left">
<xref ref-type="bibr" rid="B62">Kwon et al. (2018)</xref>
</td>
</tr>
<tr>
<td rowspan="9" align="left">Integrin</td>
<td align="center">Promote the adhesion between cells and ECM <xref ref-type="bibr" rid="B92">Place et al. (2009</xref>)</td>
<td rowspan="6" align="center">RGD</td>
<td rowspan="6" align="left">Highly repetitive conserved sequences</td>
<td rowspan="2" align="center">PEG hydrogel</td>
<td rowspan="2" align="center">Covalent bond</td>
<td rowspan="2" align="center">hPDC</td>
<td align="left">Supplemented by RGD, cells survived and proliferated better</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B61">Kudva et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="center">Participate in the mechanical signal transduction pathway of chondrocytes <xref ref-type="bibr" rid="B46">Hajos et al. (2008</xref>)</td>
<td align="left">The upregulation of cell spreading and downregulation of cell circularity confirmed the satisfying cell adhesion</td>
</tr>
<tr>
<td align="left"/>
<td align="center">Au-NPs</td>
<td align="center">Covalent bond</td>
<td align="center">hMSCs</td>
<td align="left">Au-RGD1400 stimulation exhibited higher deposition of GAGs</td>
<td align="left">
<xref ref-type="bibr" rid="B65">Li et al. (2017b)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">PEG hydrogel</td>
<td align="center">Covalent bond</td>
<td align="center">Chondrocytes</td>
<td align="left">RGD sequence was chemically crosslinked with PEG, resulting in more secretion of GAGs. A trend of hypertrophy in chondrocytes was found after stimulation of peptide RGD.</td>
<td align="left">
<xref ref-type="bibr" rid="B133">Zhang et al. (2015b)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">PEG hydrogel</td>
<td align="center">Covalent bond</td>
<td align="center">Chondrocytes</td>
<td align="left">The risk of chondrocyte dedifferentiation tended to decrease when the microscopic distance were over 70nm, indicating more beneficial to maintain the normal phenotype of chondrocytes</td>
<td align="left">
<xref ref-type="bibr" rid="B69">Li et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">PEG hydrogel</td>
<td align="center">Non-covalent bond</td>
<td align="center">Chondrocytes</td>
<td align="left">Without dynamic load, RGD had a negative effect on the phenotype of chondrocytes. Under dynamic compression, the expression of chondrogenic genes increased with the increase of RGD concentration</td>
<td align="left">
<xref ref-type="bibr" rid="B119">Villanueva et al. (2009)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="center">GRGDY</td>
<td rowspan="2" align="left">Highly repetitive conserved sequences</td>
<td rowspan="2" align="center">Calcium alginate hydrogel</td>
<td rowspan="2" align="center">Covalent bond</td>
<td align="center">Chondrocytes</td>
<td rowspan="2" align="left">Formation of ectopic cartilage on the back of rats</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B3">Alsberg et al. (2002)</xref>
</td>
</tr>
<tr>
<td align="center">Rat</td>
</tr>
<tr>
<td align="left"/>
<td align="center">CPENFFGGRGDSG</td>
<td align="center">Highly repetitive conserved sequences</td>
<td align="center">PEG hydrogel</td>
<td align="center">Covalent bond</td>
<td align="center">hMSCs</td>
<td align="left">Enzymatically cleaved CPENFFGRGDSG showed limited long-term influence on cell viability. With stimulation of CPENFFGRGDSG, the secretion of GAGs was significantly improved</td>
<td align="left">
<xref ref-type="bibr" rid="B102">Salinas and Anseth (2008)</xref>
</td>
</tr>
<tr>
<td align="left">IGF</td>
<td align="center">Induce the proliferation and chondrogenic differentiation of MSCs <xref ref-type="bibr" rid="B115">Trippel, (1995</xref>)</td>
<td align="center">GRVDWLQRNANFYDWFVAELG</td>
<td align="center">Phage Display technology</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">hMSCs</td>
<td align="left">Insulin-derived peptide of 0.1&#xa0;&#x3bc;M improved the deposition of GAGs, with the presence of TGF-&#x3b2;3</td>
<td align="left">
<xref ref-type="bibr" rid="B97">Renner and Liu (2013)</xref>
</td>
</tr>
<tr>
<td rowspan="10" align="left">PTH</td>
<td rowspan="10" align="left">Induce MSCs to differentiate into chondrocytes, but counteracting hypertrophic differentiation, so as to maintain the phenotype of chondrocyte <xref ref-type="bibr" rid="B52">Jiang et al. (2008</xref>)</td>
<td align="center">PtHrP</td>
<td rowspan="9" align="left">Highly repetitive conserved sequences</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">BMSC</td>
<td align="left">The content ratio of collagen type II to collagen type I was significantly improved by PTHrP</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B54">Kafienah et al. (2007)</xref>
</td>
</tr>
<tr>
<td align="center">(1&#x2013;34)</td>
<td align="left">The expression of collagen type X was significantly downregulated by PTHrP</td>
</tr>
<tr>
<td align="left"/>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">MSCs, hAC Rat</td>
<td align="left">PTHrP inhibited the ALP activity and gene expression of Indian hedgehog and collagen type X</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Fischer et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">MSCs</td>
<td align="left">The deposition of proteoglycan and collagen type II was promoted, and decreased expression trend of collagen type X was found</td>
<td align="left">
<xref ref-type="bibr" rid="B95">Rajagopal et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">MSCs</td>
<td align="left">PtHrP supplementation from day 4 significantly increased the expression of chondrogenic markers compared with day 14</td>
<td align="left">
<xref ref-type="bibr" rid="B134">Zhang et al. (2013)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td align="center">BMSC</td>
<td align="left">PTHrP improved the chondrogenic matrix deposition of proteoglycan and collagen type II.</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B57">Kim et al. (2008)</xref>
</td>
</tr>
<tr>
<td align="center">ADSC</td>
<td align="left">The markers of endochondral osteogenesis were inhibited</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td align="center">NC, MSC</td>
<td align="left">Implanted cell pellets that treated with PTHrP showed improved Safranin-O staining and anti-collagen type I/II IF staining results after 3 weeks</td>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B53">Johnstone et al. (1998)</xref>
</td>
</tr>
<tr>
<td align="center">Rat</td>
<td align="left">Weakly positive stains of Alizarin Red S and anti-collagen type X/CD31 IF staining were found</td>
</tr>
<tr>
<td align="center">PTHrP (1&#x2013;40)</td>
<td align="center">Highly repetitive conserved sequences</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">Rabbit</td>
<td align="left">The time window between 4 and 6 weeks for PTHrP injection benefited the rat knee cartilage repair better</td>
<td align="left">
<xref ref-type="bibr" rid="B6">Anderson-Baron et al. (2021)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3-1">
<title>3.1 TGF-&#x3b2;-related motifs</title>
<p>TGF-&#x3b2; is a family of proteins that regulates key cellular processes involved in early embryonic development (<xref ref-type="bibr" rid="B89">Peng et al., 2022</xref>), cell growth (<xref ref-type="bibr" rid="B36">Frangogiannis, 2022</xref>), differentiation (<xref ref-type="bibr" rid="B82">Moreau et al., 2022</xref>), motility, and apoptosis (<xref ref-type="bibr" rid="B123">Weiss and Attisano, 2013</xref>). As known to all, TGF-&#x3b2; is vital in maintaining articular cartilage normality and joint integration. Bhatnagar selected a series of short peptides containing six or seven amino acids from the structural characteristics of TGF-&#x3b2;, named as the CM family (<xref ref-type="bibr" rid="B14">Bhatnagar et al., 2003</xref>), and main members include CM1 (ANVAENA), CM2 (LIAEAK), and CM10 (LIANAK). El-Sakka (<xref ref-type="bibr" rid="B30">El-Sakka et al., 1997</xref>) and Basu (<xref ref-type="bibr" rid="B10">Basu et al., 2009</xref>)applied CM1 and CM10 locally in mouse skin wound model, and found improvement in collagen I expression and wound strength (<xref ref-type="fig" rid="F2">Figure 2A, B</xref>). Renner <italic>et al.</italic> cultured human mesenchymal stem cells (hMSCs) with free CM1 and CM2, but no significant difference was found in glycosaminoglycan (GAG) production, compared with negative controls (<xref ref-type="fig" rid="F2">Figure 2C</xref>) (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>). In contrast, Park <italic>et al.</italic> added CM2 into medium to culture human periodontal ligament stem cells (hPLSCs) and found increased expression of SOX9, ACAN, and COL2A1. Moreover, compared with the non-covalent binding mode, the covalently combined CM2 with Cx-HA exerted longer influence on GAG deposition (<xref ref-type="fig" rid="F2">Figure 2D</xref>) (<xref ref-type="bibr" rid="B88">Park et al., 2019</xref>). Similarly, Zhang <italic>et al.</italic> covalently grafted CM10 onto FNF-HMS and found that the functionalized scaffold strengthened chondrogenic differentiation <italic>in vitro</italic>. Then the scaffold were injected subcutaneously into mice, which showed ectopic cartilage formation (<xref ref-type="fig" rid="F2">Figure 2E</xref>) (<xref ref-type="bibr" rid="B135">Zhang et al., 2015a</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>TGF-&#x3b2; mimetic peptide CMs in cartilage regeneration. <bold>(A)</bold>. CM1 was used in mouse wound model and improved the repair efficiency of neotissue thickness <bold>(A)</bold>, calcification <bold>(B)</bold>, collagen secretion <bold>(C)</bold>, compared with control group <bold>(D)</bold> (<xref ref-type="bibr" rid="B30">El-Sakka et al., 1997</xref>). <bold>(B)</bold>. CM10 induced early epithelialization and vascularization of skin wound, so as to strengthen the collagen deposition and tissue reconstruction (<xref ref-type="bibr" rid="B10">Basu et al., 2009</xref>). <bold>(C)</bold>. Administration of CM1 and CM2 improved the GAGs production, independent of dosage (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>). <bold>(D)</bold>. Compared with physically mixed into HA hydrogel, chemically crosslinked CM2 showed stabler release curve <bold>(A)</bold> and better GAGs deposition <bold>(B)</bold> (<xref ref-type="bibr" rid="B88">Park et al., 2019</xref>). <bold>(E)</bold>. CM10 was loaded on nanofiber hollow microspheres prepared by emulsification and phase separation <bold>(A)</bold>. Safranin O staining exhibited significantly higher GAGs secretion <italic>in vitro</italic> <bold>(B)</bold>. After implanted subcutaneously in rats, the Safranin O, Von kossa and immunohistochemical stains showed better deposition of GAGs and collagen, with little calcification <bold>(C)</bold> (<xref ref-type="bibr" rid="B135">Zhang et al., 2015a</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 BMPH-related functional motifs</title>
<p>Hyaline cartilage locates at the end of the long bone, lacks blood supply and reserve cells. Its lubrication and feeding relies on articular fluid at the joint capsule. Similarly, the poor self-repair ability of articular cartilage defects is poor for that the chemokines are usually too insufficient in the defect area to guide the accumulation of stem cells (<xref ref-type="bibr" rid="B21">Chen et al., 2021</xref>). For example, BMHP is able to enter bone marrow and bind to BMSCs <italic>in vivo</italic>, which does favor to induce MSCs to migrate, proliferate, differentiate and synthesize matrix to repair cartilage defect (<xref ref-type="bibr" rid="B71">Liu et al., 2013</xref>).</p>
<p>
<xref ref-type="bibr" rid="B85">Nowakowski et al. (2004)</xref> screened a series of peptides with strong affinity for stem cells, and found that the amino acids K, <italic>p</italic>, F, S, and T are crucial for biological functions Subsequently, Gelain <italic>et al.</italic> verified the bioactivities of BMHP1 (PFSSTKT) and BMHP2 (SKPPGTSS), as mimetic peptides of BMHP that rich in amino acids K, <italic>p</italic>, F, S, and T. Stem cell recruitment was realized with the two peptides as well as an improved trend of cell differentiation (<xref ref-type="fig" rid="F3">Figure 3A</xref>) (<xref ref-type="bibr" rid="B41">Gelain et al., 2006</xref>). Lu <italic>et al.</italic> combined the PFSSTKT short peptide with RAD to produce a functionalized SAP hydrogel, which stimulated MSC proliferation, attachment, and chondrogenic differentiation in rabbit model. Acellularized cartilage matrix (ACM) scaffold was combined with SAP hydrogel to form ACM &#x2b; RAD/PFS and implanted into full-thickness articular cartilage defect area, and it was found that the cartilage defect was completely covered by chondroid tissue (<xref ref-type="fig" rid="F3">Figure 3B</xref>) (<xref ref-type="bibr" rid="B18">Cao et al., 2015</xref>; <xref ref-type="bibr" rid="B74">Lu et al., 2018</xref>). Sun <italic>et al.</italic> introduced the SKPPGTSS short peptide and RAD into a three-dimensional (3D) porous decellularized porcine articular cartilage matrix (DCM) scaffold to form a bone marrow-specific homing scaffold system, DCM-RAD/SKP. Experiments <italic>in vitro</italic> showed that rabbit bone marrow stem cells migrated to DCM-RAD/SKP scaffold, and the cell/scaffold system were implanted into rabbit knee cartilage defect model. Computed Tomography (CT) results showed that the cartilage defect area was filled with uniform regenerated tissue, highly similar with surrounding normal cartilage, and successfully reconstructed the subchondral bone (<xref ref-type="fig" rid="F3">Figure 3C</xref>) (<xref ref-type="bibr" rid="B110">Sun et al., 2018</xref>). According to studies above, the peptides PFSSTKT and SKPPFTSS successfully recruited stem to specific location, in spite of original tissue. However, PFSSTKT and SKPPFTSS exerted limited effect on differentiation, indicating that differentiation depends on other conditions, such as environment.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>BMHP-mimetic peptides, PFSSTKT and SKPPGTSS in tissue engineering. <bold>(A)</bold>. BMHP1 (PFSSTKT) and BMHP2 (SKPPGTSS) recruited NSCs to local tissue, and the cell behaviors were stable, compared with Matrixgel (<xref ref-type="bibr" rid="B41">Gelain et al., 2006</xref>). <bold>(B)</bold>. PFSSTKT in cartilage tissue engineering. RAD/PFS hydrogel did favor to the adhesion of rabbit BMSCs <bold>(A)</bold>. RAD/PFS was merged in acellularized cartilage matrix scaffold to acquire functional composite scaffold, then implanted into full-depth rabbit knee cartilage defect <bold>(B)</bold>. PFSSTKT was conjugated with peptide RADA-16 I to prepare functional self-assembling peptide hydrogel RAD/PFS <bold>(C)</bold>. Better reconstruction of articular cartilage was found after implanting RAD/PFS/ACM composite scaffold into rabbit knee cartilage defect <bold>(D)</bold> (<xref ref-type="bibr" rid="B74">Lu et al., 2018</xref>). <bold>(C)</bold>. SKPPGTSS in cartilage tissue engineering. Conjugation of RAD and SKPPGTSS, and fabrication of composite scaffold of RAD/SKP/DCM <bold>(A)</bold>. BMSCs stayed healthy on different scaffolds <bold>(B)</bold>. RAD/SKP/PFS group showed ideal neocartilage at rabbit knee cartilage defect area <bold>(C)</bold> (<xref ref-type="bibr" rid="B110">Sun et al., 2018</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 BMP-related functional motifs</title>
<p>BMPs are members of TGF-&#x3b2; family, and play an important role in regulating cell behavior and tissue regeneration (<xref ref-type="bibr" rid="B136">Zhou et al., 2022</xref>). BMPs participate in the differentiation of MSCs into bone, cartilage, ligaments, tendons, and nerves (<xref ref-type="bibr" rid="B5">An et al., 2010</xref>). Saito <italic>et al.</italic> Found that KIPKASSVPTELSAISTLYL, a 20-amino acid sequence from residues 73&#x2013;92 of BMP2, may be one of the receptor binding sites to induce calcification of fibroblasts (<xref ref-type="bibr" rid="B101">Saito et al., 2003</xref>). Renner <italic>et al.</italic> used KIPKASSVPTELSAISTLYL to culture hMSCs, and found the GAG production was higher after 2&#xa0;weeks (<xref ref-type="fig" rid="F4">Figure 4A</xref>) (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>). More importantly, Kim <italic>et al.</italic> found that compared with BMP2 group, cells treated with KIPKASSVPTELSAISTLYL exhibited almost no increase in hypertrophy markers but significantly increased secretion of cartilage matrix (<xref ref-type="fig" rid="F4">Figure 4B</xref>) (<xref ref-type="bibr" rid="B96">Renner et al., 2012</xref>). In addition, Akkiraju <italic>et al.</italic> designed a novel mimic peptide CK2.1(Syed) from BMP receptor Ia (BMPRIa) and injected it into the tail veins of mice. CK2.1 promoted chondrogenesis without inducing chondrocyte hypertrophy, and the effect was better than that of BMP (<xref ref-type="fig" rid="F4">Figure 4C</xref>) (<xref ref-type="bibr" rid="B1">Akkiraju et al., 2017a</xref>). Subsequently, Akkiraju injected CK2.1-loaded hydrogel particles (HGP) into articular cartilage defects of mice, and found that defects were filled with typical neocartilage of less hypertrophy (<xref ref-type="fig" rid="F4">Figure 4D</xref>) (<xref ref-type="bibr" rid="B2">Akkiraju et al., 2017b</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>BMP-related peptides in cartilage regeneration. <bold>(A)</bold>. BMP-mimetic peptide significantly strengthened the secretion of GAGs in hMSCs (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>). <bold>(B)</bold>. BMP peptide maintained the cartilage structure. BMP peptide did favor for cartilage matrix deposition <bold>(A)</bold>. BMP peptide reduced the secretion of collagen type X <bold>(B)</bold>. BMP peptide decreased the ALP activity of hMSCs <bold>(C)</bold> (<xref ref-type="bibr" rid="B96">Renner et al., 2012</xref>). <bold>(C).</bold> Mimetic peptide of BMP receptor type I&#x3b1;, CK2.1, suppressed hypertrophy and ossification risk of hMSCs. Schematic illustration of CK2.1 <bold>(A)</bold>. CK2.1 increased the regeneration of cartilage but decreased the expression of collagen type X and osteocalcin <bold>(B)</bold> (<xref ref-type="bibr" rid="B1">Akkiraju et al., 2017a</xref>). <bold>(D)</bold>. CK2.1-HGP improved the cartilage restoration in mice but showed no evidence of hypertrophy <bold>(A)</bold>, and lower deposition of collagen type X <bold>(B)</bold> (<xref ref-type="bibr" rid="B2">Akkiraju et al., 2017b</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 N-cadherin-related functional motifs</title>
<p>N-cadherin is a calcium ion-dependent adhesion glycoprotein and function in maintaining cell structure and motility (<xref ref-type="bibr" rid="B113">Tepass et al., 2000</xref>). In chondrogenesis, N-cadherin mediates the aggregation and condensation of mesenchymal cells, like chondrogenic progenitor cells (<xref ref-type="bibr" rid="B112">Tavella et al., 1994</xref>; <xref ref-type="bibr" rid="B99">Richardson et al., 2007</xref>). Gao suggested that N-cadherin-mediated cell-cell interactions were of great significance in mesenchymal cell densification and chondrogenesis (<xref ref-type="bibr" rid="B38">Gao et al., 2010</xref>).</p>
<p>Williams <italic>et al.</italic> found that N-cadherin has an evolutionarily conserved sequence HAV (<xref ref-type="bibr" rid="B127">Williams et al., 2000</xref>), which provides a homophile cell adhesion recognition site and mediates cell-cell adhesion (<xref ref-type="bibr" rid="B16">Blaschuk et al., 1990</xref>). Relative studies clarified that inhibition of the HAV peptide weakened cell-cell adhesion (<xref ref-type="fig" rid="F5">Figure 5A</xref>) (<xref ref-type="bibr" rid="B127">Williams et al., 2000</xref>). Williams <italic>et al.</italic> performed a series of amino acid modifications on the basic HAV sequence and synthesized peptides showed similar affinity with N-cadherin (<xref ref-type="bibr" rid="B126">Williams et al., 2001</xref>). Bian incorporated HAV into a MeHA hydrogel to promote the early expression of chondrogenic genes and latter cartilage-specific matrix production (<xref ref-type="fig" rid="F5">Figure 5B</xref>) (<xref ref-type="bibr" rid="B15">Bian et al., 2013</xref>). Cagla <italic>et al.</italic> combined HAV and the amphiphilic peptide nanofiber system E-PA, and realized promoted mesenchymal cell cohesion and cartilage formation (<xref ref-type="fig" rid="F5">Figure 5C</xref>) (<xref ref-type="bibr" rid="B31">Eren Cimenci et al., 2019</xref>). Li chemically grafted HAVDI with a KLD12 self-assembled peptide hydrogel and found that the nuclear translocation of &#x3b2;-catenin and the synthesis of type X collagen at the early stage of chondrogenesis. By the downregulation of the WNT/&#x3b2;-catenin pathway, the expression of chondrogenic genes was improved and cartilage matrix was preserved (<xref ref-type="fig" rid="F5">Figure 5D</xref>) (<xref ref-type="bibr" rid="B67">Li et al., 2017a</xref>). Kwon <italic>et al.</italic> suggested that the HAV peptide enhanced the early expression of chondrogenic markers and promoted the long-term deposition of cartilage matrix in a strongly dose-dependent manner (<xref ref-type="fig" rid="F5">Figure 5E</xref>) (<xref ref-type="bibr" rid="B62">Kwon et al., 2018</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>N-cadherin mimetic peptide HAV in cartilage engineering. <bold>(A)</bold>. Crystal structure of HAVDI (<xref ref-type="bibr" rid="B127">Williams et al., 2000</xref>). <bold>(B)</bold>. Tripeptide HAV in chondrogenesis. HAV was grafted onto MeHA hydrogel <bold>(A)</bold>, and the productions of GAGs and collagen were evaluated <italic>in vitro</italic> <bold>(B)</bold> and <italic>in vivo</italic> <bold>(C)</bold> (<xref ref-type="bibr" rid="B15">Bian et al., 2013</xref>). <bold>(C)</bold>. HAV was grafted with E-PA to get nanofiber network <bold>(A)</bold>. Cells adhered the HAV/E-PA network well <bold>(B)</bold>. Cells cultured on the HAV/E-PA scaffold secreted more GAGs <bold>(C)</bold>, and showed higher expression of chondrogenesis (<xref ref-type="bibr" rid="B31">Eren Cimenci et al., 2019</xref>). <bold>(D)</bold>. Self-assembling peptide KLD-HAVDI mimic the functional domain of N-cadherin <bold>(A)</bold>. With stimulation of HAVDI, the secretion of GAGs and genetic expression of chondrogenesis were upgraded <bold>(B&#x2013;C)</bold>. Meanwhile, the subcellular localization changed <bold>(D)</bold> (<xref ref-type="bibr" rid="B67">Li et al., 2017a</xref>). <bold>(E).</bold> HAV was grafted to MeHA for crosslinking <bold>(A)</bold>, and hydrogels of different proportion were prepared <bold>(B)</bold>. HAV strengthened the expressions of early chondrogenic markers, depending on the dosage strongly <bold>(C)</bold> (<xref ref-type="bibr" rid="B62">Kwon et al., 2018</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Integrin-related functional motifs</title>
<p>Integrin is an adhesion protein on the membrane that can transmit signals by interacting with extracellular matrix (ECM), so as to regulate key cellular processes, such as cell differentiation, proliferation and migration (<xref ref-type="bibr" rid="B63">LaFlamme et al., 2018</xref>). Interestingly, integrin can improve the adhesion between cells and ECM, and allow cells to adapt to the surrounding environment better (<xref ref-type="bibr" rid="B92">Place et al., 2009</xref>). RGD sequence has been found in multiple ECM proteins that promote cell adhesion, such as fibronectin (<xref ref-type="bibr" rid="B116">Underwood et al., 1995</xref>), laminin (<xref ref-type="bibr" rid="B121">Wang et al., 2021</xref>), tenascin (<xref ref-type="bibr" rid="B25">Comisar et al., 2007</xref>), and thrombospondin (<xref ref-type="bibr" rid="B13">Benoit and Anseth, 2005</xref>). RGD binds integrins to anchor cells on the surface of matrix and enhance cell migration, adhesion, extension, and proliferation. Patterson <italic>et al.</italic> grafted RGD to polyethylene glycol (PEG) hydrogels to culture human periosteum-derived cells (hPDCs). The cells maintained high viability and promoted the expression of chondrogenic genes and synthesis of GAGs (<xref ref-type="fig" rid="F6">Figure 6A</xref>) (<xref ref-type="bibr" rid="B61">Kudva et al., 2018</xref>). Li <italic>et al.</italic> conjugated RGD to gold nanoparticles (Au-NPs) and improved differentiation of hMSCs into chondrocytes (<xref ref-type="fig" rid="F6">Figure 6B</xref>) (<xref ref-type="bibr" rid="B65">Li et al., 2017b</xref>). Alsberg <italic>et al.</italic> injected mixture of calcium alginate hydrogel-GRGDY-chondrocytes subcutaneously at the backs of rats, and found typical ectopic chondrogenesis (<xref ref-type="fig" rid="F6">Figure 6C</xref>) (<xref ref-type="bibr" rid="B3">Alsberg et al., 2002</xref>). However, Zhang <italic>et al.</italic> suggested that RGD peptides promote chondrocyte proliferation and differentiation, but simultaneously lead to chondrocyte hypertrophy and differentiation (<xref ref-type="fig" rid="F6">Figure 6D</xref>) (<xref ref-type="bibr" rid="B133">Zhang et al., 2015b</xref>). Salinas <italic>et al.</italic> believed that the influence of RGD on cells based on time. When the cleavable CPENFFGGRGDSG system was added to the PEG hydrogel loaded with hMSCs, early chondrogenesis could be induced. The removal of RGD reduced the risk of inhibited chondrogenesis (<xref ref-type="fig" rid="F6">Figure 6E</xref>) (<xref ref-type="bibr" rid="B102">Salinas and Anseth, 2008</xref>). Li <italic>et al.</italic> cultured chondrocytes in PEG hydrogel loaded with RGD. The chondrocyte dedifferentiation was inhibited when the microscopic distance was over 70&#xa0;nm. Then, 70&#xa0;nm was consider the most beneficial distance of RGD stimulation to maintain the phenotype of chondrocytes (<xref ref-type="fig" rid="F6">Figure 6F</xref>) (<xref ref-type="bibr" rid="B69">Li et al., 2015</xref>). Mechanical stimulation was also thought of as one factor that affects RGD function, according to the role of integrin in the mechanical signal transduction pathway of chondrocytes. Studies by Villanueva showed that RGD has a negative effect on the phenotype of chondrocytes without a dynamic load. However, the phenotype of chondrocytes could be maintained after dynamic compression (<xref ref-type="fig" rid="F6">Figure 6G</xref>) (<xref ref-type="bibr" rid="B119">Villanueva et al., 2009</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Peptides mimicking integrin and insulin in cartilage restoration. <bold>(A)</bold>. RGD sequence functioned the PEG-VS was crosslinked <italic>via</italic> di-thiol crosslinker <bold>(A)</bold>. Supplemented by RGD, cells survived and proliferated better <bold>(B&#x2013;C)</bold>. Besides, the upregulation of cell spreading and downregulation of cell circularity confirmed the satisfying cell adhesion <bold>(D)</bold> (<xref ref-type="bibr" rid="B61">Kudva et al., 2018</xref>). <bold>(B)</bold>. Peptide RGD was conjugated onto Au-nanoparticals <bold>(A)</bold>. Au-RGD1400 stimulation exhibited higher deposition of GAGs <bold>(B)</bold> (<xref ref-type="bibr" rid="B65">Li et al., 2017b</xref>). <bold>(C)</bold>. Peptide G-RGD-Y stimulated chondrocytes turned out typical collagen distribution by Masson stain <bold>(A)</bold>. The bovine articular chondrocytes and calvarial osteoblasts were mixed and loaded into RGD-modified alginate scaffold, which turned into neocartilage of larger size <bold>(B)</bold>, mass <bold>(C)</bold> and high-density image under X-ray <bold>(D)</bold> (<xref ref-type="bibr" rid="B3">Alsberg et al., 2002</xref>). <bold>(D)</bold>. RGD sequence was chemically crosslinked with PEG <bold>(A)</bold>, resulting in more secretion of GAGs <bold>(B)</bold>. However, a trend of hypertrophy in chondrocytes was found after stimulation of peptide RGD <bold>(C)</bold> (<xref ref-type="bibr" rid="B133">Zhang et al., 2015b</xref>). <bold>(E)</bold>. Chemical formulas of enzymatically cleavable peptide CPENFFGRGDSG <bold>(A)</bold> and uncleavable peptide CRGDSG <bold>(B)</bold>. Enzymatically cleaved CPENFFGRGDSG showed limited long-term influence on cell viability <bold>(C)</bold>. With stimulation of CPENFFGRGDSG, the secretion of GAGs was significantly improved <bold>(D)</bold> (<xref ref-type="bibr" rid="B102">Salinas and Anseth, 2008</xref>). <bold>(F)</bold>. RGD was grafted on PEG hydrogel to stimulate MSCs <bold>(A)</bold>. Expression of chondrogenic genes on different nanospacings after 10 days <bold>(B&#x2013;D)</bold> (<xref ref-type="bibr" rid="B69">Li et al., 2015</xref>). <bold>(G)</bold>. Dynamic mechanical loading was exerted on MSCs after 24-h cultivation <bold>(A)</bold>. RGD alleviated the trend of morphology change after straining <bold>(B)</bold> (<xref ref-type="bibr" rid="B119">Villanueva et al., 2009</xref>). <bold>(H)</bold>. Insulin-derived peptide of 0.1&#xa0;&#x3bc;M improved the deposition of GAGs, with the presence of TGF-&#x3b2;3 (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 IGF-related functional motifs</title>
<p>Both insulin and insulin-like growth factor 1 (IGF1) play key roles in chondrogenesis. Insulin, an important component in almost all chondrogenic supplements (<xref ref-type="bibr" rid="B93">Puetzer et al., 2010</xref>), was reported to be significant in chondrocyte redifferentiation and could independently induce cartilage matrix synthesis of chondrogenic cell line ATDC5 (<xref ref-type="bibr" rid="B105">Shukunami et al., 1996</xref>). IGF1 is an important growth factor in chondrogenesis and the regulator of cartilage homeostasis. IGF1 promotes expression of chondrogenic gene, synthesis of collagen type II and proteoglycans, cell proliferation, and inhibits matrix decomposition mediated by osteoclasts (<xref ref-type="bibr" rid="B115">Trippel, 1995</xref>). IGF1 was found to interact with insulin receptors. Therefore, insulin-related peptides may also play a role similar to that of insulin and IGF1 for cross-reactivity (<xref ref-type="bibr" rid="B90">Phornphutkul et al., 2006</xref>). Renner <italic>et al.</italic> designed an insulin-mimetic peptide, GRVDWLQRNANFYDWFVAELG (GRV), which exhibited a high affinity for the insulin receptor. Then, the peptide GRV at different dosage of 0.01 &#xb5;M, 0.1 &#xb5;M, and 1&#xa0;&#xb5;M were used to culture hMSC. The results showed that differentiated chondrocytes, originating from hMSCs containing peptide GRV and TGF-&#x3b2;3, secreted more GAG than the control group of TGF-&#x3b2;3. It is believed that, with the presence of insulin and TGF-&#x3b2;3, the insulin functional motif GRV promoted chondrogenic differentiation and cartilage matrix deposition (<xref ref-type="fig" rid="F6">Figure 6H</xref>) (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>).</p>
</sec>
<sec id="s3-7">
<title>3.7 Parathyroid hormone (PTH) functional motifs</title>
<p>PTH is a single-chain polypeptide hormone synthesized and secreted by parathyroid cells (<xref ref-type="bibr" rid="B111">Suva and Friedman, 2022</xref>). PTH can regulate calcium and phosphorus metabolism at bone, kidneys and small intestine (<xref ref-type="bibr" rid="B72">Lombardi et al., 2020</xref>). The differentiation of MSCs into chondrocytes is usually accompanied with terminal hypertrophic differentiation (<xref ref-type="bibr" rid="B34">Fischer et al., 2010</xref>). PTH guides the differentiation of MSCs into chondrocytes (<xref ref-type="bibr" rid="B20">Chang et al., 2009</xref>) but counteracts hypertrophic differentiation (<xref ref-type="bibr" rid="B52">Jiang et al., 2008</xref>), so as to maintain the pehnotype of chondrocytes (<xref ref-type="bibr" rid="B57">Kim et al., 2008</xref>; <xref ref-type="bibr" rid="B124">Weiss et al., 2010</xref>). Suva <italic>et al.</italic> (<xref ref-type="bibr" rid="B83">Moseley et al., 1987</xref>) found that parathyroid hormone-associated protein (PTHrP) and PTH share similar sequence at residues 1&#x2013;34, and exert similar effects by the same receptor, PTH1R (<xref ref-type="bibr" rid="B125">Weisser et al., 2002</xref>). <xref ref-type="bibr" rid="B54">Kafienah et al. (2007)</xref>
<italic>.</italic> demonstrated that PTHrP can inhibit the hypertrophic differentiation of BMSC (<xref ref-type="fig" rid="F7">Figure 7A</xref>) Fischer <italic>et al.</italic> cultured BMSCs with PTHrP in conditioned medium from human articular chondrocytes, and successfully reduced the expression of hypertrophy markers such as COL10A1 and alkaline phosphatase (<xref ref-type="fig" rid="F7">Figure 7B</xref>) (<xref ref-type="bibr" rid="B34">Fischer et al., 2010</xref>). Meanwhile, Fischer <italic>et al.</italic> cultured MSCs in an environment of continuous or intermittent PtHrP(1&#x2013;34) stimulation. The results showed that continuous stimulation inhibited chondrogenic differentiation of MSCs, whereas intermittent stimulation increased the deposition of cartilage matrix but inhibited hypertrophic differentiation (<xref ref-type="fig" rid="F7">Figure 7C</xref>) (<xref ref-type="bibr" rid="B33">Fischer et al., 2014</xref>). In addition, the point of stimulation time on chondrogenesis was also studued. Rajagopal <italic>et al.</italic> supplemented PtHrP (1&#x2013;34) into chondrogenic medium from day 4, and found that chondrogenic markers were significantly increased. At the same time, hypertrophy markers were significantly reduced compared to those treated with PtHrP from day 14 (<xref ref-type="fig" rid="F7">Figure 7D</xref>) (<xref ref-type="bibr" rid="B95">Rajagopal et al., 2021</xref>). <xref ref-type="bibr" rid="B57">Kim et al. (2008)</xref> supplemented PTHrP (1&#x2013;34) into chondrogenic medium for BMSCs and adipose tissue mesenchymal stem cells (ADSCs) from 14th day. The staining results indicated promoted chondrogenesis and inhibited hypertrophy <italic>in vitro</italic> (<xref ref-type="fig" rid="F7">Figure 7E</xref>) (<xref ref-type="bibr" rid="B57">Kim et al., 2008</xref>). <xref ref-type="bibr" rid="B134">Zhang et al. (2013)</xref> injected PTHrP(1&#x2013;40) in the articular cavity of rabbits at three time points after osteochondral injury. The results showed that, at 4&#x2013;6 weeks group, articular cartilage exhibited better morphology and lower expression of hypertrophy markers than others (<xref ref-type="fig" rid="F7">Figure 7F</xref>) (<xref ref-type="bibr" rid="B134">Zhang et al., 2013</xref>). Baron <italic>et al.</italic> cocultured human nasal septal chondrocytes with MSCs (NC/MSC) in a 1:3 ratio and added PTHrP. The results indicated that PTHrP inhibited the expression of hypertrophic markers in a dose-dependent manner and promoted secretion of cartilage matrix. PTHrP was found to eliminate cartilage calcification <italic>in vivo</italic> after the implantation of PTHrP-containing pellets into immunodeficient nude mice. In contrast, the control group exhibited obvious cartilage calcification (<xref ref-type="fig" rid="F7">Figure 7G</xref>) (<xref ref-type="bibr" rid="B6">Anderson-Baron et al., 2021</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>PTH-related peptide (PTHrP) in osteoarthritis. <bold>(A)</bold>. PTHrP prevented the hypertrophy of chondrocytes. Collagen quantification results that the content ratio of collagen type II to collagen type I was significantly improved by PTHrP <bold>(A)</bold>, while the proteoglycan exhibited no difference by DMMB assay <bold>(B)</bold>. However, the expression of collagen type X was significantly downregulated by PTHrP, as qPCR results (<xref ref-type="bibr" rid="B54">Kafienah et al., 2007</xref>). <bold>(B)</bold>. PTHrP inhibited the endochondral indexes of ALP activity and mRNA expression of Indian hedgehog and collagen type X (<xref ref-type="bibr" rid="B34">Fischer et al., 2010</xref>). <bold>(C)</bold>. Pulsative stimulation of PTHrP was performed on chondrocytes <bold>(A)</bold>. The deposition of proteoglycan and collagen type II was promoted <bold>(B)</bold>, and decreased expression trend of collagen type X was found <bold>(C)</bold> (<xref ref-type="bibr" rid="B33">Fischer et al., 2014</xref>). <bold>(D)</bold>. Supplemented PTHrP from fourth day strengthened the cartilage matrix deposition of periosteal MSCs and bone marrow MSCs by Alcian blue <bold>(A)</bold>, but suppressed the endochondral osteogenesis, as immunohistochemical (IHC) staining of collagen type X <bold>(B)</bold> (<xref ref-type="bibr" rid="B95">Rajagopal et al., 2021</xref>). <bold>(E)</bold>. PTHrP improved the chondrogenic matrix deposition of proteoglycan and collagen type II by Safranin-O staining and IHC staining <bold>(A)</bold>. However, the markers of endochondral osteogenesis were inhibited, such as collagen type I, collagen type X and Runx-2 by IHC staining (<xref ref-type="bibr" rid="B57">Kim et al., 2008</xref>). <bold>(F)</bold>. The time window between 4 and 6 weeks for PTHrP injection benefited the rat knee cartilage repair best, as the result of gross morphology <bold>(A)</bold> and Safranin-O staining <bold>(B)</bold> (<xref ref-type="bibr" rid="B134">Zhang et al., 2013</xref>). <bold>(G)</bold>. Implanted cell pellets that treated with PTHrP showed improved Safranin-O staining and anti-collagen type I/II IF staining after 3 weeks <bold>(A)</bold>. Meanwhile, weakly positive stains of Alizarin Red S and anti-collagen type X/CD31 IF staining were found <bold>(B)</bold> (<xref ref-type="bibr" rid="B6">Anderson-Baron et al., 2021</xref>).</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>4 Carriers of existing functional motifs</title>
<p>Protein-mimetic peptides require suitable scaffold carriers to release in the recipient area, so as to achieve desired repair effect. Therefore, it is significantly meaningful to design safe, effective, and stable carriers for transporting functional motifs. Current scaffold carriers of motif in cartilage tissue engineering were as follows, including artificial materials and natural materials (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Carrier classifications based on material source.</p>
</caption>
<graphic xlink:href="fbioe-11-1127949-g008.tif"/>
</fig>
<sec id="s4-1">
<title>4.1 Natural materials</title>
<p>Natural materials, such as liposomes, collagen, and polysaccharide compounds, are popular for wide sources and low cost. In addition, they show high stability, safety, hydrophilicity, and other advantages. However, disadvantages also exist, such as low drug loading and poor adhesion to cells. Therefore, natural materials need modification or combination with other materials.</p>
<sec id="s4-1-1">
<title>4.1.1 Liposomes</title>
<p>Since liposomes were discovered by Bangham in the 1960s, their unique structure and properties exhibited excellent application prospects as carriers of oligonucleotides (<xref ref-type="bibr" rid="B39">Garbuzenko et al., 2009</xref>), polypeptides (<xref ref-type="bibr" rid="B46">Hajos et al., 2008</xref>), and proteins (<xref ref-type="bibr" rid="B70">Liu et al., 1993</xref>). As carriers, liposomes have many advantages. 1) Targeted effect. The structure of liposomes is similar to that of the vesicles (<xref ref-type="bibr" rid="B100">Rideau et al., 2018</xref>), which can directly enter cells by endocytosis of target cells. 2) Low immunogenicity, low-toxicity, and high-biocompatibility. 3) Broad drug loading. For their bimolecular lipid layer structure, liposomes can load lipid-soluble drugs between lipid membranes, amphiphilic drugs on phospholipids, and hydrophilic drugs in the aqueous phase. However, some disadvantages of liposomes should be noticed. Firstly, designing and applying the nano-delivery of liposomes require complicated technologies. Secondly, the cost of liposome formulations in industrialized production remains high. Finally, the stability and targeting, as well as potential toxicity of liposomal delivery systems are insufficient. Therefore, it is of great significance to solve the problems before wide application of liposome in clinical.</p>
</sec>
<sec id="s4-1-2">
<title>4.1.2 Collagen</title>
<p>Collagen is a main component of connective tissue in mammals and structural component of bones (<xref ref-type="bibr" rid="B47">Halper and Kjaer, 2014</xref>).There are different types of collagen. Previous researches found collagen type I mainly in skin, tendon tissues and fibrous cartilage, collagen type II mainly in hyaluronan cartilage, collagen type X mainly in hydrophobic cartilage (<xref ref-type="bibr" rid="B98">Ricard-Blum, 2011</xref>). In clinical, collagen type I is the most popular collagen as carrier materials of peptide motifs. Collagen possesses multiple advantages (<xref ref-type="bibr" rid="B42">Gelse et al., 2003</xref>). 1) Sufficient sources to acquire and extract. 2) Low-immunogenicity, low-toxicity and good biocompatibility. 3) Long-term release behavior (<xref ref-type="bibr" rid="B76">Maeda et al., 2001</xref>). 4) Excellent structure plasticity (<xref ref-type="bibr" rid="B120">Wallace and Rosenblatt, 2003</xref>). 5) Various bioactivities, such as promotion of blood clotting. However, some disadvantages exist. 1) High cost of purification. 2) Rapid swelling and degradation due to hydrophilicity. 3) Poor mechanical properties. Therefore, the application of collagen as carriers requires more exploration.</p>
</sec>
<sec id="s4-1-3">
<title>4.1.3 Demineralized bone matrix (DBM)</title>
<p>DBM based on removing bone mineral components but preserving natural protein components, calcium-based solids, inorganic phosphates and polysaccharides. In 1965, Urist found that DBM can induce osteogenesis (<xref ref-type="bibr" rid="B117">URIST and STRATES, 1970</xref>). Decalcification can expose and activate osteo-inductive proteins, enabling allogeneic bone to have an active osteo-inductive capacity for implanted bone resorption and new bone formation (<xref ref-type="bibr" rid="B44">Gloivacki, 1985</xref>). In addition, DBM has good biocompatibility, bioactivity, and biodegradability, and is easy to integrate into the surrounding bone and cartilage, so as to support the restoration of local tissue (<xref ref-type="bibr" rid="B132">Zhang et al., 2019</xref>). As a popular biomaterial, DBM still has a few difficulties. Firstly, the structure of DBM is too loose to fixed at the defect area. Secondly, the DBM of standard morphology usually could not fit the defect area well, resulting in tissue gap and inferior healing. Therefore, more morphological modification of DBM are required in cartilage tissue engineering.</p>
</sec>
<sec id="s4-1-4">
<title>4.1.4 Chitosan</title>
<p>Chitosan is a deacetylated polysaccharide material originating from chitin. The surface of chitosan is hydrophilic and can promote cell adhesion, proliferation, and differentiation. In addition, the positive charge of the surface exhibits antibacterial activity and good biocompatibility. In 2000, Suhjk proposed that chitosan-based implants cause little allogeneic Immune Responses and fiber wrapping (<xref ref-type="bibr" rid="B108">Suh and Matthew, 2000</xref>). Jia <italic>et al.</italic> encapsulated rabbit synovial mesenchymal stem cells (SMSCs) in injectable chitosan hydrogels and implanted them into rabbit femoral cartilage defect model. Results showed that cartilage repair in the experimental group was significantly strengthened (<xref ref-type="bibr" rid="B51">Jia et al., 2019</xref>). <xref ref-type="bibr" rid="B32">Fang et al. (2014)</xref> co-cultured chondrocytes with porous poly (l-glutamic acid)/chitosan polyelectrolyte microspheres. Results showed that the microspheres improved the attachment and proliferation of chondrocytes. Experiments <italic>in vivo</italic> showed that chondrocytes/microsphere complex successfully repair cartilage tissue, making them an effective carrier for cartilage tissue engineering.</p>
</sec>
<sec id="s4-1-5">
<title>4.1.5 Hyaluronic acid (HA)</title>
<p>HA, a linear macromolecular polysaccharide that widely distributed in human tissues and the ECM, is another widely used polysaccharide. HA can promote the migration, proliferation, and aggregation of bone cells, improve cell viscosity and support the survival of chondrocytes, so as to function in the generation of cartilage-bone. Therefore, HA and its derivative hydrogels are widely used as carriers for functional motifs (<xref ref-type="bibr" rid="B88">Park et al., 2019</xref>).</p>
</sec>
<sec id="s4-1-6">
<title>4.1.6 Calcium alginate</title>
<p>Calcium alginate is a polysaccharide rich in guluronic acid and mannuronic acid. The advantages of adequate sources, low cost and low toxicity, as well as good absorbability, injectability, and biocompatibility attract the attention of researchers in drug delivery studies. Calcium alginate hydrogel has a large surface area and many internal pores, which is conducive to cell adhesion and material exchange. In 1989, Guo <italic>et al.</italic> firstly 3D-cultured chondrocytes in calcium alginate and observed that chondrocytes steadily proliferate and secrete the cartilage matrix (<xref ref-type="bibr" rid="B45">Guo et al., 1989</xref>). In 1995, <xref ref-type="bibr" rid="B86">Paige et al. (1995)</xref> subcutaneously implanted chondrocyte/calcium alginate complex into the backs of rats. After 6 weeks, ectopic hyaline cartilage was found (<xref ref-type="bibr" rid="B86">Paige et al., 1995</xref>). In 2002, <xref ref-type="bibr" rid="B3">Alsberg et al. (2002)</xref> injected chondrocyte/RGD/calcium alginate mixture into the backs of rats and detected ectopic cartilage formation.</p>
</sec>
</sec>
<sec id="s4-2">
<title>4.2 Artificial synthetic materials</title>
<p>Synthetic material refers to artificially produced micromolecular monomers. Through chemical crosslinking, casting mold or 3D printing technology, the monomers assembled into macromolecular polymer materials. With excellent biocompatibility, highly standardized properties, mass production capacity, modification potential, and low immunogenicity, synthetic materials exhibit great potential as carriers in tissue engineering and regenerative medicine.</p>
<sec id="s4-2-1">
<title>4.2.1 Polymer materials</title>
<p>Polycaprolactone (PCL), polylactic acid (PLA), and other synthetic polymer compounds exhibited good biocompatibility and biodegradability, but their hydrophobic property limits the applications as carriers for hydrophilic peptides. Polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyglycolic acid (PGA), polyethyleneimine (PEI) and other synthetic polymer compounds have good hydrophilicity, but are easy to degrade. PCL is widely used in biomedical research and has been approved for clinical application by the Food and Drug Administration (FDA) (<xref ref-type="bibr" rid="B81">Mkhabela and Ray, 2014</xref>). <xref ref-type="bibr" rid="B77">Malheiro et al. (2010)</xref> firstly reported the preparation of PCL/chitosan blend fibers and their application as scaffolds in tissue engineering in 2010. Poly(lactic-co-glycolic acid) (PLGA) is composed of lactic acid and glycolic acid. The biocompatibility and biodegradability of PLGA have also been approved by the FDA for clinical use. <xref ref-type="bibr" rid="B56">Kim et al. (2019)</xref> implanted fibrous PLGA scaffolds loaded with BMP7 and synovial mesenchymal stem cells into full-thickness rabbit cartilage defects, and realized higher secretion of proteoglycan and type II collagen, indicating better reconstruction of hyaline cartilage (<xref ref-type="bibr" rid="B56">Kim et al., 2019</xref>). In 2010, <xref ref-type="bibr" rid="B122">Wang et al. (2010)</xref> designed a composite structure of BMSCs/PDNA-TGF-&#x3b2;1/fibrin gel/PLGA sponge, and implanted it into cartilage defect area. After 12&#xa0;weeks, the new cartilage came out and integrated well with the surrounding tissues.</p>
</sec>
<sec id="s4-2-2">
<title>4.2.2 Micromolecular self-assembly materials</title>
<p>Some peptides can self-assemble by non-covalent interactions like hydrogen bonds, Van der Waals force and hydrophobic bonds. The assembling properties could be adjusted by modifying amino acid sequences and environmental parameters, so as to get nanostructures of various morphologies, including nanoribbons, nanotubes, spherical vesicles, nanofibers, nanowires, and ordered molecular chains (<xref ref-type="bibr" rid="B107">Smith et al., 2011</xref>). Self-assembly peptides exhibit various advantages of simple preparation, good biocompatibility, large functional surface, easy modification and excellent tissue permeability, therefore become a hotspot in cartilage tissue engineering (<xref ref-type="bibr" rid="B60">Knowles and Mezzenga, 2016</xref>). Previously, our team grafted TGF-&#x3b2;1-mimetic peptide, CM10, to self-assembling peptide hydrogel RADA16-1, and implanted it into full-thickness rabbit knee cartilage defect. Finally, effectively promoted chondrogenic differentiation of rabbit BMSCs <italic>in vitro</italic> and significant reconstruction of osteochondral units were found (<xref ref-type="bibr" rid="B131">Ye et al., 2022</xref>).<xref ref-type="bibr" rid="B74">Lu et al. (2018)</xref>, Sun (<xref ref-type="bibr" rid="B110">Sun et al., 2018</xref>), <xref ref-type="bibr" rid="B137">Zhu et al. (2022)</xref> respectively grafted the sequences PFSSTKT and SKPPGTSS, derived from BMHP1, onto RADA16-1 hydrogel. Significantly strengthened recruitment of bone marrow stem cells (BMSCs) were found at the defect areas, according to their studies.</p>
<p>The temperature-responsive self-assembly of DNA opens up new space for the design of nanomaterials. Tetrahedral DNA nanostructures (TDNs) (<xref ref-type="bibr" rid="B68">Li et al., 2019</xref>), with advantages of small structure, blood circulation and simple preparation, gradually become good carriers of micromolecules. Contrary to self-assembling peptide, TDNs benefit from easier production and better thermostability. Moreover, TDNs showed excellent biocompatibility and biosafety compared to other inorganic nanomaterials (<xref ref-type="bibr" rid="B22">Chen et al., 2014</xref>). <xref ref-type="bibr" rid="B66">Li et al. (2011)</xref> grafted the bioactive nucleic acid molecule CpG to one chain of TDN by DNA hybridization, so as to introduce the functional fragment into macrophages through the endocytosis of TDN. Compared with the CpG monomer, the immune stimulation effect of functional TDN was significantly improved (<xref ref-type="bibr" rid="B66">Li et al., 2011</xref>). <xref ref-type="bibr" rid="B64">Lee et al. (2012)</xref> used TDN as an siRNA carrier and connected it with targeting molecule, folic acid, then successfully delivered siRNA to the solid tumor site of mice. After grafted onto TDN, siRNA showed significantly prolonged half-life <italic>in vivo</italic>, compared to monomer siRNA.</p>
</sec>
</sec>
</sec>
<sec id="s5">
<title>5 Modifications on functional motifs</title>
<sec id="s5-1">
<title>5.1 Non-covalent bonding</title>
<p>Non-covalent bonding mainly involves van der Waals forces, hydrophobic bonds, hydrogen bonds, and charge distribution. Non-covalent binding immobilizes active peptides on the surface of the material, mainly through physical adsorption force, so as to promote cell adhesion, proliferation, and differentiation. Simple dispersal is commonly used for physical adsorption. Kantlehner <italic>et al.</italic> physically immobilized RGD on titanium surface and achieved improved adhesion of osteoblasts (<xref ref-type="bibr" rid="B55">Kantlehner et al., 2000</xref>; <xref ref-type="bibr" rid="B78">Mas-Moruno et al., 2014</xref>). However, owing to the weak binding force, low adsorption rate, poor stability and repeatability, the application of non-covalent bonds is still limited.</p>
</sec>
<sec id="s5-2">
<title>5.2 Covalent bonding</title>
<p>Chemical coupling is a typical method of covalent bonding. After introducing active groups (such as -NH2, -OH, -COOH, and active hydrogen) on the surfaces of the carrier, the peptides reacts with carrier by crosslinking agents (CDI, APTES, PPY, and SMP) (<xref ref-type="bibr" rid="B87">Pallarola et al., 2014</xref>), leading to improved physical and chemical properties of peptides, such as stability and controlled release behavior (<xref ref-type="bibr" rid="B138">Zreiqat et al., 2003</xref>).</p>
<p>In cartilage tissue engineering, complicated techniques, such as layer-by-layer self-assembling technique, are often used to modify composite scaffold. The principle is that compounds are deposited alternately layer by layer, by interaction between monomers including the strong binding force of chemical bonds and the weak binding force of non-covalent bonds. In this way, the monomers of different layers can spontaneously form a film with stable properties and specific functions. Chua <italic>et al.</italic> used layer-by-layer self-assembly technology to prepare a HA/chitosan/PEM/titanium substrate, and chemically crosslink it with RGD, so as to improve the adhesion and proliferation of osteoblasts (<xref ref-type="bibr" rid="B24">Chua et al., 2008</xref>). Moreover, Yang <italic>et al.</italic> developed a polydopamine (PDA) coating layer under weak alkaline condition, which increased the adhesion of nerve growth factor (NGF) increased, and promoted the differentiation and proliferation of human neural stem cells (NSC) (<xref ref-type="bibr" rid="B130">Yang et al., 2012</xref>). This is based on the super-adhesive effect of the PDA coating, and the improved hydrophilicity and cell adhesion ensured the immobilization and bioactivity of peptides.</p>
</sec>
</sec>
<sec id="s6">
<title>6 Advantages and disadvantages of functional motifs</title>
<p>In general, existing growth factor products have several disadvantages. 1) Natural growth factors originate from animal vectors, which suffers from medical ethics and immunogenicity. 2) The high cost and low output during preparation and purification. 3) Complicated structures, especially after multiple processing in different chemical and physical microenvironments. 4) Poor biological stability. Due to the short biological half-life (<xref ref-type="bibr" rid="B28">Di, 2015</xref>), growth factors are easily degraded and inactivated, and usually need to be applied in large dosages to achieve the therapeutic goals. These limits hindered the widespread use of growth factors. To solve this problem, functional motifs were developed, and have exhibit remarkable advantages. The characteristics of motifs and proteins are listed in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Characteristics of motifs and proteins.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">Motif</th>
<th align="center">Protein</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Sequence length</td>
<td align="center">Short</td>
<td align="center">Long</td>
</tr>
<tr>
<td align="center">Synthesis technique</td>
<td align="center">Solid phase synthesis/Flow chemistry, easy</td>
<td align="center">Recombinant protein expression in <italic>E. coli</italic>, complicated</td>
</tr>
<tr>
<td align="center">Immunogenicity</td>
<td align="center">Weak</td>
<td align="center">Strong</td>
</tr>
<tr>
<td align="center">Stability</td>
<td align="center">Easier degradation and dilution</td>
<td align="center">Relatively stabler</td>
</tr>
<tr>
<td align="center">Modification</td>
<td align="center">Easy modification for ending blocking and anti-degradation</td>
<td align="center">Complicated modification of anti-degradation</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s6-1">
<title>6.1 Advantages of functional motifs</title>
<p>Synthetic peptides are superior to natural proteins in some ways. Firstly, functional motifs have good physical and chemical properties. 1) Functional motifs are peptide segments composed of amino acids, with simple structure and easy to adjust. 2) Functional motif can be loaded into different carriers by various methods, while maintained biological activity and stability. Zhang <italic>et al.</italic> added an extra cysteine residue to the C-terminus of CM10, which promoted the coupling of CM10 to the carrier, thereby improving the stability and function time of CM10 (<xref ref-type="bibr" rid="B135">Zhang et al., 2015a</xref>). Secondly, the functional motif has excellent biological properties. 1) The production of motifs by solid-phase synthesis does not require animal vectors. The low immunogenicity and no ethical issues make it possible in clinical application. 2) Excellent biocompatibility and biodegradability in natural physiological environments (<xref ref-type="bibr" rid="B114">Tiwari et al., 2012</xref>). 3) Potential targeting performance. Liposomes that bound with RGD peptide had been reported to exhibit targeting behaviors (<xref ref-type="bibr" rid="B27">Dharap et al., 2003</xref>). In a word, functional motifs can be directly synthesized in large quantities for their simple structures and low production costs. Therefore, functional motifs are increasingly popular in tissue engineering and regenerative medicine (<xref ref-type="bibr" rid="B103">Sekiya et al., 2002</xref>).</p>
</sec>
<sec id="s6-2">
<title>6.2 Disadvantages of functional motifs</title>
<p>However, functional motifs also face some shortcomings in terms of efficacy and physical properties. As a polymer of amino acids, peptides may be inactivated for chemical degradations and physical changes under complicated environments. Moreover, some functional motifs show limited efficiency when compared with cytokines. For instance, Renner <italic>et al.</italic> supplemented TGF-&#x3b2;1- related motifs, CM1 and CM2, to culture hMSCs, and the results showed that cell pellets only produced significantly lower GAG compared with TGF-&#x3b2;1 positive controls (12%&#x2013;13% for CM1 and 7% for CM2) (<xref ref-type="bibr" rid="B97">Renner and Liu, 2013</xref>).</p>
</sec>
</sec>
<sec id="s7">
<title>7 Research prospects of functional motifs in cartilage regeneration</title>
<p>Functional motifs have attracted extensive attention in the field of cartilage tissue engineering, owing to their simple structure, tunability, diverse functions, and low cost. Through reasonable design of microscopic structures and biological groups, peptide motifs can form nanostructures with specific morphologies and functions, which would make difference in chondrogenic researches. Future explorations on functional motifs should focus on the following aspects.</p>
<sec id="s7-1">
<title>7.1 Biostability of functional motifs</title>
<p>Compared to macromolecular proteins, short peptide sequences are shorter and more easily to degrade by various proteases in organisms. In the future, short peptide molecules should be designed and synthesized, and the sequences should be modified to obtain more stable. For example, the stability of functional motif can be improved by ending blocking of acetylation and amidation, as well as blocking of ubiquitin modification sites.</p>
</sec>
<sec id="s7-2">
<title>7.2 Biological activity of functional motifs</title>
<p>Specific peptides of short sequence may only mimic partial structures of the functional domains. Thus, the administration dosages of short peptides are usually higher than that of whole proteins. Therefore, further researches are required to improve the simulation efficiency of biological activity with shorter sequences.</p>
</sec>
<sec id="s7-3">
<title>7.3 Self-assembly of functional motifs</title>
<p>Peptides may form granular, tubular, radial, fibrous mesh, and other specific configurations by self-assembling, which can improve the adhesion and integration with defect areas. However, the microstructure also affects the bioactivity. How to obtain a balance between structure and function is a challenge in future researchers.</p>
</sec>
<sec id="s7-4">
<title>7.4 Application prospect of functional motifs</title>
<p>Short peptides and their carrier scaffolds remain the hotspots in tissue engineering researches and clinical practice. Application researches should be conducted based on the following aspects.</p>
<p>Firstly, the interface between cartilage and subchondral bone is calcification layer, which bears the mechanical stress of defect area. The interface layer is convex to the cartilage, leading to stress concentration and mechanical load. In future studies, we should focus on the mechanism and growth factors involved in formation of calcification interface.</p>
<p>In addition, endochondral ossification shares similar biological processes with cartilage degeneration and osteoarthritis progression, including chondrocyte hypertrophy, apoptosis, and degradation of the cartilage matrix. It is vital to explore that whether peptide motifs participated in the processes, and how to regulate the cartilage matrix absorption and chondrogenic regeneration.</p>
<p>Finally, previous studies based on the biological function of scaffold on cells or organs, but how does motifs and factors exert influence on scaffold materials need to be studied. The morphology and content of regenerative biomaterials influences the repair effect. For example, physiological regulation of pH can be used for scaffold shaping, such as self-assembly peptides, HA, and thermosensitive hydrogels, to adapt to the morphology of defect area. In addition, appropriate degradation of active groups in composite scaffolds make it possible to exert specific bioactivity at different time points.</p>
</sec>
</sec>
</body>
<back>
<sec id="s8">
<title>Author contributions</title>
<p>SQ: Reading references. Writing original draft. Drawing pictures and tables. JZ: Revising the manuscript. Drawing pictures and tables. GZ: Reading references. QS: Reading references. YN: Collecting references. WY: Reviewing and Editing the draft. GM: Funding acquisition. Supervision. HL: Funding acquisition. Reviewing the draft.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>We acknowledge the financial support from the National Natural Science Foundation of China (Grant Nos. 62171077, 61871068, 81671827).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akkiraju</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bonor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nohe</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>CK2. 1, a novel peptide, induces articular cartilage formation <italic>in vivo</italic>
</article-title>. <source>J. Orthop. Res.</source> <volume>35</volume> (<issue>4</issue>), <fpage>876</fpage>&#x2013;<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1002/jor.23342</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akkiraju</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Safran</surname>
<given-names>C. B. K.</given-names>
</name>
<name>
<surname>Nohe</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>CK2. 1, a bone morphogenetic protein receptor type Ia mimetic peptide, repairs cartilage in mice with destabilized medial meniscus</article-title>. <source>Stem Cell Res. Ther.</source> <volume>8</volume> (<issue>1</issue>), <fpage>82</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13287-017-0537-y</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alsberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Albeiruti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rowley</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Mooney</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Engineering growing tissues</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>99</volume> (<issue>19</issue>), <fpage>12025</fpage>&#x2013;<lpage>12030</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.192291499</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al&#x2010;Majdoub</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thiesen</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Glocker</surname>
<given-names>M. O.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mass spectrometric and peptide chip characterization of an assembled epitope: Analysis of a polyclonal antibody model serum directed against the sj&#xf8;gren/systemic lupus erythematosus autoantigen TRIM21</article-title>. <source>J. Mass Spectrom.</source> <volume>48</volume> (<issue>6</issue>), <fpage>651</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1002/jms.3208</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells</article-title>. <source>Ann. Biomed. Eng.</source> <volume>38</volume> (<issue>4</issue>), <fpage>1647</fpage>&#x2013;<lpage>1654</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-009-9892-x</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson-Baron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kunze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mulet-Sierra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Osswald</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Suppression of hypertrophy during <italic>in vitro</italic> chondrogenesis of cocultures of human mesenchymal stem cells and nasal chondrocytes correlates with lack of <italic>in vivo</italic> calcification and vascular invasion</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>572356</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.572356</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrae</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gallini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Betsholtz</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Role of platelet-derived growth factors in physiology and medicine</article-title>. <source>Genes &#x26; Dev.</source> <volume>22</volume> (<issue>10</issue>), <fpage>1276</fpage>&#x2013;<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1653708</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballinger</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Shyamala</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Forrest</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Deuter-Reinhard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. x.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Semirational design of a potent, artificial agonist of fibroblast growth factor receptors</article-title>. <source>Nat. Biotechnol.</source> <volume>17</volume> (<issue>12</issue>), <fpage>1199</fpage>&#x2013;<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1038/70746</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banner</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>D&#x27;Arcy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Janes</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gentz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schoenfeld</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Broger</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>1993</year>). <article-title>Crystal structure of the soluble human 55 kd TNF receptor-human TNF&#x3b2; complex: Implications for TNF receptor activation</article-title>. <source>Cell</source> <volume>73</volume> (<issue>3</issue>), <fpage>431</fpage>&#x2013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90132-a</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chansuria</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>V. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Effect of Cytomodulin-10 (TGF-&#xdf;1 analogue) on wound healing by primary intention in a murine model</article-title>. <source>Int. J. Surg.</source> <volume>7</volume> (<issue>5</issue>), <fpage>460</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijsu.2009.07.005</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beenken</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The FGF family: Biology, pathophysiology and therapy</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>8</volume> (<issue>3</issue>), <fpage>235</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2792</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behrendt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Offer</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Advances in Fmoc solid&#x2010;phase peptide synthesis</article-title>. <source>J. Peptide Sci.</source> <volume>22</volume> (<issue>1</issue>), <fpage>4</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/psc.2836</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benoit</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Anseth</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces</article-title>. <source>Biomaterials</source> <volume>26</volume> (<issue>25</issue>), <fpage>5209</fpage>&#x2013;<lpage>5220</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2005.01.045</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bhatnagar</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Gough</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2003</year>). <comment>Peptide compositions mimicking TGF-&#x3b2; activity</comment>. <publisher-loc>California, United States</publisher-loc>: <publisher-name>Google Patents</publisher-name>.</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guvendiren</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mauck</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Burdick</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>110</volume> (<issue>25</issue>), <fpage>10117</fpage>&#x2013;<lpage>10122</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1214100110</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaschuk</surname>
<given-names>O. W.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pouliot</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Identification of a cadherin cell adhesion recognition sequence</article-title>. <source>Dev. Biol.</source> <volume>139</volume> (<issue>1</issue>), <fpage>227</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(90)90290-y</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blumenfeld</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Laufer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Livne</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Effects of transforming growth factor-&#x3b2;1 and interleukin-1&#x3b1; on matrix synthesis in osteoarthritic cartilage of the temporo-mandibular joint in aged mice</article-title>. <source>Mech. ageing Dev.</source> <volume>95</volume> (<issue>1-2</issue>), <fpage>101</fpage>&#x2013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/s0047-6374(97)01869-1</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>F.-Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>W. N.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>R. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A novel function of BMHP1 and cBMHP1 peptides to induce the osteogenic differentiation of mesenchymal stem cells</article-title>. <source>Biomaterials Sci.</source> <volume>3</volume> (<issue>2</issue>), <fpage>345</fpage>&#x2013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1039/c4bm00300d</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cool</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Nurcombe</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>E. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Endogenous regeneration: Engineering growth factors for stroke</article-title>. <source>Neurochem. Int.</source> <volume>107</volume>, <fpage>57</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2017.03.024</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. S.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Parathyroid hormone 1&#x2013;34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats</article-title>. <source>Arthritis &#x26; Rheumatism Official J. Am. Coll. Rheumatology</source> <volume>60</volume> (<issue>10</issue>), <fpage>3049</fpage>&#x2013;<lpage>3060</lpage>. <pub-id pub-id-type="doi">10.1002/art.24843</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X. N.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R. Q.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Molecular mechanisms of chondrocyte proliferation and differentiation</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>9</volume>, <fpage>664168</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.664168</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Physical and biochemical insights on DNA structures in artificial and living systems</article-title>. <source>accounts Chem. Res.</source> <volume>47</volume> (<issue>6</issue>), <fpage>1720</fpage>&#x2013;<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1021/ar400324n</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>I. Y.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>T. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Ocular anti-VEGF therapy for diabetic retinopathy: Overview of clinical efficacy and evolving applications</article-title>. <source>Diabetes care</source> <volume>37</volume> (<issue>4</issue>), <fpage>900</fpage>&#x2013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.2337/dc13-1990</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chua</surname>
<given-names>P.-H.</given-names>
</name>
<name>
<surname>Neoh</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion</article-title>. <source>Biomaterials</source> <volume>29</volume> (<issue>10</issue>), <fpage>1412</fpage>&#x2013;<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.12.019</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comisar</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Kazmers</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mooney</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Linderman</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: A combined computational and experimental approach</article-title>. <source>Biomaterials</source> <volume>28</volume> (<issue>30</issue>), <fpage>4409</fpage>&#x2013;<lpage>4417</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.06.018</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>S.-K.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts</article-title>. <source>Medicine</source> <volume>99</volume> (<issue>24</issue>), <fpage>e20253</fpage>. <pub-id pub-id-type="doi">10.1097/md.0000000000020253</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dharap</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Sinko</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Minko</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides</article-title>. <source>J. Control. release</source> <volume>91</volume> (<issue>1-2</issue>), <fpage>61</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/s0168-3659(03)00209-8</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Strategic approaches to optimizing peptide ADME properties</article-title>. <source>AAPS J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>134</fpage>&#x2013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-014-9687-3</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dower</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Cwirla</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Baccanari</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Peptide agonists of the thrombopoietin receptor</article-title>. <source>Stem cells</source> <volume>16</volume> (<issue>S1</issue>), <fpage>21</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1002/stem.5530160705</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sakka</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Hassoba</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Chui</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Dahiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lue</surname>
<given-names>T. F.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>An animal model of Peyronie&#x27;s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression</article-title>. <source>J. urology</source> <volume>158</volume> (<issue>6</issue>), <fpage>2284</fpage>&#x2013;<lpage>2290</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-5347(01)68236-3</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eren Cimenci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kurtulus</surname>
<given-names>G. U.</given-names>
</name>
<name>
<surname>Caliskan</surname>
<given-names>O. S.</given-names>
</name>
<name>
<surname>Guler</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Tekinay</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>N-cadherin mimetic peptide nanofiber system induces chondrogenic differentiation of mesenchymal stem cells</article-title>. <source>Bioconjugate Chem.</source> <volume>30</volume> (<issue>9</issue>), <fpage>2417</fpage>&#x2013;<lpage>2426</lpage>. <pub-id pub-id-type="doi">10.1021/acs.bioconjchem.9b00514</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Poly (L-glutamic acid)/chitosan polyelectrolyte complex porous microspheres as cell microcarriers for cartilage regeneration</article-title>. <source>Acta biomater.</source> <volume>10</volume> (<issue>1</issue>), <fpage>276</fpage>&#x2013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2013.09.002</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aulmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dexheimer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Grossner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Intermittent PTHrP (1&#x2013;34) exposure augments chondrogenesis and reduces hypertrophy of mesenchymal stromal cells</article-title>. <source>Stem cells Dev.</source> <volume>23</volume> (<issue>20</issue>), <fpage>2513</fpage>&#x2013;<lpage>2523</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2014.0101</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dickhut</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rickert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis</article-title>. <source>Arthritis Rheum.</source> <volume>62</volume> (<issue>9</issue>), <fpage>2696</fpage>&#x2013;<lpage>2706</lpage>. <pub-id pub-id-type="doi">10.1002/art.27565</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foong</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S. Q.</given-names>
</name>
<name>
<surname>Uttamchandani</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Current advances in peptide and small molecule microarray technologies</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>16</volume> (<issue>1-2</issue>), <fpage>234</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2011.12.007</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frangogiannis</surname>
<given-names>N. G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Transforming growth factor-&#x3b2; in myocardial disease</article-title>. <source>Nat. Rev. Cardiol.</source> <volume>19</volume>, <fpage>435</fpage>&#x2013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-021-00646-w</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funakoshi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Hepatocyte growth factor: From diagnosis to clinical applications</article-title>. <source>Clin. Chim. acta</source> <volume>327</volume> (<issue>1-2</issue>), <fpage>1</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/s0009-8981(02)00302-9</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McBeath</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin</article-title>. <source>Stem cells</source> <volume>28</volume> (<issue>3</issue>), <fpage>564</fpage>&#x2013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1002/stem.308</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garbuzenko</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Saad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Betigeri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vetcher</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Soldatenkov</surname>
<given-names>V. A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug</article-title>. <source>Pharm. Res.</source> <volume>26</volume> (<issue>2</issue>), <fpage>382</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-008-9755-4</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaseitsiwe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valentini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mahdavifar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hoft</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Zerweck</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from <italic>M. tuberculosis</italic>
</article-title>. <source>PloS one</source> <volume>3</volume> (<issue>12</issue>), <fpage>e3840</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0003840</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gelain</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bottai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vescovi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures</article-title>. <source>PloS one</source> <volume>1</volume> (<issue>1</issue>), <fpage>e119</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0000119</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gelse</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>P&#xf6;schl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aigner</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Collagens&#x2014;Structure, function, and biosynthesis</article-title>. <source>Adv. drug Deliv. Rev.</source> <volume>55</volume> (<issue>12</issue>), <fpage>1531</fpage>&#x2013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2003.08.002</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geysen</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Bodnar</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Markworth</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Parke</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Schoenen</surname>
<given-names>F. J.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Isotope or mass encoding of combinatorial libraries</article-title>. <source>Chem. Biol.</source> <volume>3</volume> (<issue>8</issue>), <fpage>679</fpage>&#x2013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/s1074-5521(96)90136-2</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gloivacki</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Demineralized bone implants</article-title>. <source>Clin. plastic Surg.</source> <volume>12</volume> (<issue>2</issue>), <fpage>233</fpage>&#x2013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/s0094-1298(20)31694-1</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jourdian</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Maccallum</surname>
<given-names>D. K.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Culture and growth characteristics of chondrocytes encapsulated in alginate beads</article-title>. <source>Connect. tissue Res.</source> <volume>19</volume> (<issue>2-4</issue>), <fpage>277</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.3109/03008208909043901</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hensler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Prassl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mosgoeller</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Inhalable liposomal formulation for vasoactive intestinal peptide</article-title>. <source>Int. J. Pharm.</source> <volume>357</volume> (<issue>1-2</issue>), <fpage>286</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2008.01.046</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Halper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kjaer</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Basic components of connective tissues and extracellular matrix: Elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins</article-title>. <source>Progress in heritable soft connective tissue diseases</source>, <fpage>31</fpage>&#x2013;<lpage>47</lpage>.</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanft</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pollak</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barbul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gils</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers</article-title>. <source>J. wound care</source> <volume>17</volume> (<issue>1</issue>), <fpage>30</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.12968/jowc.2008.17.1.27917</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ornitz</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease</article-title>. <source>J. Biochem.</source> <volume>149</volume> (<issue>2</issue>), <fpage>121</fpage>&#x2013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1093/jb/mvq121</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakobsen</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Engebretsen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Slauterbeck</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>An analysis of the quality of cartilage repair studies</article-title>. <source>JBJS</source> <volume>87</volume> (<issue>10</issue>), <fpage>2232</fpage>&#x2013;<lpage>2239</lpage>. <pub-id pub-id-type="doi">10.2106/jbjs.d.02904</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Repair of osteochondral defects using injectable chitosan-based hydrogel encapsulated synovial fluid-derived mesenchymal stem cells in a rabbit model</article-title>. <source>Mater. Sci. Eng. C</source> <volume>99</volume>, <fpage>541</fpage>&#x2013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2019.01.115</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mung</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hidaka</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Interaction between zonal populations of articular chondrocytes suppresses chondrocyte mineralization and this process is mediated by PTHrP</article-title>. <source>Osteoarthr. Cartil.</source> <volume>16</volume> (<issue>1</issue>), <fpage>70</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2007.05.014</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnstone</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hering</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J. U.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>In Vitro Chondrogenesis of bone marrow-derived mesenchymal progenitor cells</article-title>. <source>Exp. Cell Res.</source> <volume>238</volume> (<issue>1</issue>), <fpage>265</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1997.3858</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kafienah</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Learmonth</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hollander</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Three&#x2010;dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients</article-title>. <source>Arthritis &#x26; Rheumatism</source> <volume>56</volume> (<issue>1</issue>), <fpage>177</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1002/art.22285</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantlehner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schaffner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Finsinger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jonczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Diefenbach</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation</article-title>. <source>Chembiochem</source> <volume>1</volume> (<issue>2</issue>), <fpage>107</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/1439-7633(20000818)1:2&#x3c;107:aid-cbic107&#x3e;3.0.co;2-4</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>M. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair</article-title>. <source>J. Control. Release</source> <volume>302</volume>, <fpage>169</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2019.04.002</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>G.-I.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs</article-title>. <source>Biochem. biophysical Res. Commun.</source> <volume>373</volume> (<issue>1</issue>), <fpage>104</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.05.183</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hokugo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kurosawa</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Regeneration of anterior cruciate ligament by biodegradable scaffold combined with local controlled release of basic fibroblast growth factor and collagen wrapping</article-title>. <source>Tissue Eng. Part C. Methods</source> <volume>14</volume> (<issue>1</issue>), <fpage>47</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1089/tec.2007.0286</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitamura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Machigashira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakagami</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hirofuji</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>FGF-2 stimulates periodontal regeneration: Results of a multi-center randomized clinical trial</article-title>. <source>J. Dent. Res.</source> <volume>90</volume> (<issue>1</issue>), <fpage>35</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1177/0022034510384616</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knowles</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Mezzenga</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Amyloid fibrils as building blocks for natural and artificial functional materials</article-title>. <source>Adv. Mater.</source> <volume>28</volume> (<issue>31</issue>), <fpage>6546</fpage>&#x2013;<lpage>6561</lpage>. <pub-id pub-id-type="doi">10.1002/adma.201505961</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudva</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Luyten</surname>
<given-names>F. P.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>RGD&#x2010;functionalized polyethylene glycol hydrogels support proliferation and <italic>in vitro</italic> chondrogenesis of human periosteum&#x2010;derived cells</article-title>. <source>J. Biomed. Mater. Res. Part A</source> <volume>106</volume> (<issue>1</issue>), <fpage>33</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.36208</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Vega</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Gramlich</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mauck</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Burdick</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dose and timing of N&#x2010;cadherin mimetic peptides regulate MSC chondrogenesis within hydrogels</article-title>. <source>Adv. Healthc. Mater.</source> <volume>7</volume> (<issue>9</issue>), <fpage>1701199</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201701199</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaFlamme</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Mathew-Steiner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Colello-Borges</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nieves</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Integrin and microtubule crosstalk in the regulation of cellular processes</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>75</volume> (<issue>22</issue>), <fpage>4177</fpage>&#x2013;<lpage>4185</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-018-2913-x</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lytton-Jean</surname>
<given-names>A. K. R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Karagiannis</surname>
<given-names>E. D.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Molecularly self-assembled nucleic acid nanoparticles for targeted <italic>in vivo</italic> siRNA delivery</article-title>. <source>Nat. Nanotechnol.</source> <volume>7</volume> (<issue>6</issue>), <fpage>389</fpage>&#x2013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/nnano.2012.73</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kawazoe</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Induction of chondrogenic differentiation of human mesenchymal stem cells by biomimetic gold nanoparticles with tunable RGD density</article-title>. <source>Adv. Healthc. Mater.</source> <volume>6</volume> (<issue>14</issue>), <fpage>1700317</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201700317</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides</article-title>. <source>ACS Nano</source> <volume>5</volume> (<issue>11</issue>), <fpage>8783</fpage>&#x2013;<lpage>8789</lpage>. <pub-id pub-id-type="doi">10.1021/nn202774x</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>D. S. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Self-assembled N-cadherin mimetic peptide hydrogels promote the chondrogenesis of mesenchymal stem cells through inhibition of canonical Wnt/&#x3b2;-catenin signaling</article-title>. <source>Biomaterials</source> <volume>145</volume>, <fpage>33</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.08.031</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Advances in biological applications of self-assembled DNA tetrahedral nanostructures</article-title>. <source>Mater. Today</source> <volume>24</volume>, <fpage>57</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.mattod.2018.08.002</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effects of RGD nanospacing on chondrogenic differentiation of mesenchymal stem cells</article-title>. <source>J. Mater. Chem. B</source> <volume>3</volume> (<issue>26</issue>), <fpage>5197</fpage>&#x2013;<lpage>5209</lpage>. <pub-id pub-id-type="doi">10.1039/c5tb00455a</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.-Y.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kildsig</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Pulmonary delivery of free and liposomal insulin</article-title>. <source>Pharm. Res.</source> <volume>10</volume> (<issue>2</issue>), <fpage>228</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1023/a:1018934810512</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Functionalized self-assembling peptide nanofiber hydrogels mimic stem cell niche to control human adipose stem cell behavior <italic>in vitro</italic>
</article-title>. <source>Acta biomater.</source> <volume>9</volume> (<issue>6</issue>), <fpage>6798</fpage>&#x2013;<lpage>6805</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2013.01.027</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ziemann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Banfi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Corbetta</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Physical activity-dependent regulation of parathyroid hormone and calcium-phosphorous metabolism</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>15</issue>), <fpage>5388</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21155388</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowman</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Skelton</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Tomlinson</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Sadick</surname>
<given-names>M. D.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions</article-title>. <source>Biochemistry</source> <volume>37</volume> (<issue>25</issue>), <fpage>8870</fpage>&#x2013;<lpage>8878</lpage>. <pub-id pub-id-type="doi">10.1021/bi980426e</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration</article-title>. <source>Theranostics</source> <volume>8</volume> (<issue>18</issue>), <fpage>5039</fpage>&#x2013;<lpage>5058</lpage>. <pub-id pub-id-type="doi">10.7150/thno.26981</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tomokiyo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monnouchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akamine</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Prospective potency of TGF-&#x3b2;1 on maintenance and regeneration of periodontal tissue</article-title>. <source>Int. Rev. Cell Mol. Biol.</source> <volume>304</volume>, <fpage>283</fpage>&#x2013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-407696-9.00006-3</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kadota</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kajihara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Sustained release of human growth hormone (hGH) from collagen film and evaluation of effect on wound healing in db/db mice</article-title>. <source>J. Control. release</source> <volume>77</volume> (<issue>3</issue>), <fpage>261</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/s0168-3659(01)00512-0</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malheiro</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Caridade</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Mano</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>New poly (&#x3b5;-caprolactone)/chitosan blend fibers for tissue engineering applications</article-title>. <source>Acta Biomater.</source> <volume>6</volume> (<issue>2</issue>), <fpage>418</fpage>&#x2013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2009.07.012</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mas-Moruno</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fraioli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Albericio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Manero</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>F. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Novel peptide-based platform for the dual presentation of biologically active peptide motifs on biomaterials</article-title>. <source>ACS Appl. Mater. interfaces</source> <volume>6</volume> (<issue>9</issue>), <fpage>6525</fpage>&#x2013;<lpage>6536</lpage>. <pub-id pub-id-type="doi">10.1021/am5001213</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mascarenhas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Saltzman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fortier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Role of platelet-rich plasma in articular cartilage injury and disease</article-title>. <source>J. knee Surg.</source> <volume>28</volume> (<issue>01</issue>), <fpage>003</fpage>&#x2013;<lpage>010</lpage>. <pub-id pub-id-type="doi">10.1055/s-0034-1384672</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLennan</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Koishi</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The transforming growth factor-betas: Multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and schwann cells</article-title>. <source>Int. J. Dev. Biol.</source> <volume>46</volume> (<issue>4</issue>), <fpage>559</fpage>&#x2013;<lpage>567</lpage>.</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mkhabela</surname>
<given-names>V. J.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Poly(&#x3c;I&#x26;gt;&#x3b5;&#x3c;/I&#x26;gt;-caprolactone) nanocomposite scaffolds for tissue engineering: A brief overview</article-title>. <source>J. Nanosci. Nanotechnol.</source> <volume>14</volume> (<issue>1</issue>), <fpage>535</fpage>&#x2013;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2014.9055</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreau</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Velegraki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bolyard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rosenblum</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Transforming growth factor&#x2013;&#x3b2;1 in regulatory T cell biology</article-title>. <source>Sci. Immunol.</source> <volume>7</volume> (<issue>69</issue>), <fpage>eabi4613</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.abi4613</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moseley</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diefenbach-Jagger</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wettenhall</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Suva</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>1987</year>). <article-title>Parathyroid hormone-related protein purified from a human lung cancer cell line</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>84</volume> (<issue>14</issue>), <fpage>5048</fpage>&#x2013;<lpage>5052</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.84.14.5048</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tallis</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>V. T.</given-names>
</name>
<name>
<surname>Mozingo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>G. F.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Treatment of nonhealing diabetic foot ulcers with a platelet&#x2010;derived growth factor gene&#x2010;activated matrix (GAM501): Results of a Phase 1/2 trial</article-title>. <source>Wound repair Regen.</source> <volume>17</volume> (<issue>6</issue>), <fpage>772</fpage>&#x2013;<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475x.2009.00541.x</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowakowski</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Dooner</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Valinski</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Mihaliak</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Quesenberry</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells</article-title>. <source>Stem cells</source> <volume>22</volume> (<issue>6</issue>), <fpage>1030</fpage>&#x2013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.22-6-1030</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paige</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Cima</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Yaremchuk</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Vacanti</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Vacanti</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Injectable cartilage</article-title>. <source>Plastic Reconstr. Surg.</source> <volume>96</volume> (<issue>6</issue>), <fpage>1390</fpage>&#x2013;<lpage>1398</lpage>. <pub-id pub-id-type="doi">10.1097/00006534-199511000-00024</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pallarola</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bochen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rechenmacher</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sobahi</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Spatz</surname>
<given-names>J. P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Interface immobilization chemistry of cRGD&#x2010;based peptides regulates integrin mediated cell adhesion</article-title>. <source>Adv. Funct. Mater.</source> <volume>24</volume> (<issue>7</issue>), <fpage>943</fpage>&#x2013;<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1002/adfm.201302411</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>An injectable, click-crosslinked, cytomodulin-modified hyaluronic acid hydrogel for cartilage tissue engineering</article-title>. <source>NPG Asia Mater.</source> <volume>11</volume> (<issue>1</issue>), <fpage>30</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/s41427-019-0130-1</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Targeting TGF-&#x3b2; signal transduction for fibrosis and cancer therapy</article-title>. <source>Mol. Cancer</source> <volume>21</volume> (<issue>1</issue>), <fpage>104</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1186/s12943-022-01569-x</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phornphutkul</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.-Y.</given-names>
</name>
<name>
<surname>Gruppuso</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The role of insulin in chondrogenesis</article-title>. <source>Mol. Cell. Endocrinol.</source> <volume>249</volume> (<issue>1-2</issue>), <fpage>107</fpage>&#x2013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2006.02.002</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierschbacher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hayman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ruoslahti</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>The cell attachment determinant in fibronectin</article-title>. <source>J. Cell. Biochem.</source> <volume>28</volume> (<issue>2</issue>), <fpage>115</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.240280205</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Place</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Complexity in biomaterials for tissue engineering</article-title>. <source>Nat. Mater.</source> <volume>8</volume> (<issue>6</issue>), <fpage>457</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/nmat2441</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puetzer</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Petitte</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Loboa</surname>
<given-names>E. G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Comparative review of growth factors for induction of three-dimensional <italic>in vitro</italic> chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue</article-title>. <source>Tissue Eng. Part B Rev.</source> <volume>16</volume> (<issue>4</issue>), <fpage>435</fpage>&#x2013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2009.0705</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raducanu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hunziker</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Drosse</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aszodi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>&#x3b2;1 integrin deficiency results in multiple abnormalities of the knee joint</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume> (<issue>35</issue>), <fpage>23780</fpage>&#x2013;<lpage>23792</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m109.039347</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ramesh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Madhuri</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Early addition of parathyroid hormone&#x2013;related peptide regulates the hypertrophic differentiation of mesenchymal stem cells</article-title>. <source>Cartilage</source> <volume>13</volume>, <fpage>143S</fpage>&#x2013;<lpage>152S</lpage>. <pub-id pub-id-type="doi">10.1177/1947603519894727</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renner</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Bone morphogenetic protein-derived peptide promotes chondrogenic differentiation of human mesenchymal stem cells</article-title>. <source>Tissue Eng. Part A</source> <volume>18</volume> (<issue>23-24</issue>), <fpage>2581</fpage>&#x2013;<lpage>2589</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2011.0400</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renner</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Investigating the effect of peptide agonists on the chondrogenic differentiation of human mesenchymal stem cells using design of experiments</article-title>. <source>Biotechnol. Prog.</source> <volume>29</volume> (<issue>6</issue>), <fpage>1550</fpage>&#x2013;<lpage>1557</lpage>. <pub-id pub-id-type="doi">10.1002/btpr.1808</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricard-Blum</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The collagen family</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>3</volume> (<issue>1</issue>), <fpage>a004978</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a004978</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Starborg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Meadows</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Kadler</surname>
<given-names>K. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Tendon development requires regulation of cell condensation and cell shape via cadherin-11-mediated cell-cell junctions</article-title>. <source>Mol. Cell. Biol.</source> <volume>27</volume> (<issue>17</issue>), <fpage>6218</fpage>&#x2013;<lpage>6228</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00261-07</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rideau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dimova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schwille</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wurm</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Landfester</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Liposomes and polymersomes: A comparative review towards cell mimicking</article-title>. <source>Chem. Soc. Rev.</source> <volume>47</volume> (<issue>23</issue>), <fpage>8572</fpage>&#x2013;<lpage>8610</lpage>. <pub-id pub-id-type="doi">10.1039/c8cs00162f</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ogata</surname>
<given-names>S. i.</given-names>
</name>
<name>
<surname>Ohtsuki</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tanihara</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope</article-title>. <source>Biochimica Biophysica Acta (BBA)-Proteins Proteomics</source> <volume>1651</volume> (<issue>1-2</issue>), <fpage>60</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/s1570-9639(03)00235-8</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salinas</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Anseth</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities</article-title>. <source>Biomaterials</source> <volume>29</volume> (<issue>15</issue>), <fpage>2370</fpage>&#x2013;<lpage>2377</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2008.01.035</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekiya</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vuoristo</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Prockop</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>
<italic>In vitro</italic> cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>99</volume> (<issue>7</issue>), <fpage>4397</fpage>&#x2013;<lpage>4402</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.052716199</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sellers</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Peluso</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage</article-title>. <source>JBJS</source> <volume>79</volume> (<issue>10</issue>), <fpage>1452</fpage>&#x2013;<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.2106/00004623-199710000-00002</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukunami</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shigeno</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Atsumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishizeki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hiraki</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 <italic>in vitro</italic>: Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor</article-title>. <source>J. Cell Biol.</source> <volume>133</volume> (<issue>2</issue>), <fpage>457</fpage>&#x2013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.133.2.457</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J. K.</given-names>
</name>
</person-group> (<year>1993</year>). &#x201c;<article-title>[15] Libraries of peptides and proteins displayed on filamentous phage</article-title>,&#x201d; in <source>Methods in enzymology</source> (<publisher-name>Elsevier</publisher-name>), <fpage>228</fpage>&#x2013;<lpage>257</lpage>.</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Tejeda-Montes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Poch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mata</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Integrating top-down and self-assembly in the fabrication of peptide and protein-based biomedical materials</article-title>. <source>Chem. Soc. Rev.</source> <volume>40</volume> (<issue>9</issue>), <fpage>4563</fpage>&#x2013;<lpage>4577</lpage>. <pub-id pub-id-type="doi">10.1039/c1cs15064b</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname>
<given-names>J.-K. F.</given-names>
</name>
<name>
<surname>Matthew</surname>
<given-names>H. W.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review</article-title>. <source>Biomaterials</source> <volume>21</volume> (<issue>24</issue>), <fpage>2589</fpage>&#x2013;<lpage>2598</lpage>. <pub-id pub-id-type="doi">10.1016/s0142-9612(00)00126-5</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chattopadhaya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S. Q.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Recent developments in microarray-based enzyme assays: From functional annotation to substrate/inhibitor fingerprinting</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>386</volume> (<issue>3</issue>), <fpage>416</fpage>&#x2013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-006-0511-5</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>
<italic>In situ</italic> articular cartilage regeneration through endogenous reparative cell homing using a functional bone marrow-specific scaffolding system</article-title>. <source>ACS Appl. Mater. interfaces</source> <volume>10</volume> (<issue>45</issue>), <fpage>38715</fpage>&#x2013;<lpage>38728</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b11687</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Suva</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2022</year>). <source>Structural pharmacology of PTH and PTHrP</source>. <publisher-loc>Pittsburgh</publisher-loc>: <publisher-name>Academic Press</publisher-name>, <fpage>1</fpage>.</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavella</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Raffo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tacchetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cancedda</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Castagnola</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>N-CAM and N-cadherin expression during <italic>in vitro</italic> chondrogenesis</article-title>. <source>Exp. Cell Res.</source> <volume>215</volume> (<issue>2</issue>), <fpage>354</fpage>&#x2013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1994.1352</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tepass</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Truong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Godt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ikura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peifer</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Cadherins in embryonic and neural morphogenesis</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>1</volume> (<issue>2</issue>), <fpage>91</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1038/35040042</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bannerjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bhati</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Drug delivery systems: An updated review</article-title>. <source>Int. J. Pharm. investigation</source> <volume>2</volume> (<issue>1</issue>), <fpage>2</fpage>. <pub-id pub-id-type="doi">10.4103/2230-973x.96920</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trippel</surname>
<given-names>S. B.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Growth factor actions on articular cartilage</article-title>. <source>J. Rheumatology. Suppl.</source> <volume>43</volume>, <fpage>129</fpage>&#x2013;<lpage>132</lpage>.</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Underwood</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bean</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>B. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Evidence for the location of a binding sequence for the &#x3b1; 2 &#x3b2; 1 integrin of endothelial cells, in the &#x3b2; 1 subunit of laminin</article-title>. <source>Biochem. J.</source> <volume>309</volume> (<issue>3</issue>), <fpage>765</fpage>&#x2013;<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1042/bj3090765</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urist</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Strates</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>1970</year>). <article-title>29 bone formation in implants of partially and wholly demineralized bone matrix: Including observations on acetone-fixed intra and extracellular proteins</article-title>. <source>Clin. Orthop. Relat. Research&#xae;</source> <volume>71</volume>, <fpage>271</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1097/00003086-197007000-00031</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uttamchandani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S. Q.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Protein and small molecule microarrays: Powerful tools for high-throughput proteomics</article-title>. <source>Mol. Biosyst.</source> <volume>2</volume> (<issue>1</issue>), <fpage>58</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1039/b513935j</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villanueva</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Weigel</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Cell&#x2013;matrix interactions and dynamic mechanical loading influence chondrocyte gene expression and bioactivity in PEG-RGD hydrogels</article-title>. <source>Acta biomater.</source> <volume>5</volume> (<issue>8</issue>), <fpage>2832</fpage>&#x2013;<lpage>2846</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2009.05.039</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Rosenblatt</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Collagen gel systems for sustained delivery and tissue engineering</article-title>. <source>Adv. drug Deliv. Rev.</source> <volume>55</volume> (<issue>12</issue>), <fpage>1631</fpage>&#x2013;<lpage>1649</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2003.08.004</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <source>Mutations in the cell-binding motif of lam-3/laminin &#x3b1; reveal hypercontraction behavior and defective sensitivity to levamisole in <italic>Caenorhabditis elegans</italic>
</source>. <publisher-loc>California, United States</publisher-loc>: <publisher-name>Micropublication Biology</publisher-name>, <fpage>2021</fpage>.</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>
<italic>In vivo</italic> restoration of full-thickness cartilage defects by poly (lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes</article-title>. <source>Biomaterials</source> <volume>31</volume> (<issue>23</issue>), <fpage>5953</fpage>&#x2013;<lpage>5965</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.04.029</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Attisano</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The TGFbeta superfamily signaling pathway</article-title>. <source>Wiley Interdiscip. Rev. Dev. Biol.</source> <volume>2</volume> (<issue>1</issue>), <fpage>47</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.86</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>StEck</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells</article-title>. <source>J. Cell. physiology</source> <volume>223</volume> (<issue>1</issue>), <fpage>84</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.22013</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weisser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Riemer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schmidl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suva</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Poschl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brauer</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Four distinct chondrocyte populations in the fetal bovine growth plate: Highest expression levels of PTH/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1&#x2013;34) and PTHrP (1&#x2013;40)</article-title>. <source>Exp. Cell Res.</source> <volume>279</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1006/excr.2002.5580</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>E.-J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Skaper</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume> (<issue>47</issue>), <fpage>43879</fpage>&#x2013;<lpage>43886</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m105876200</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gour</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Blaschuk</surname>
<given-names>O. W.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif</article-title>. <source>J. Biol. Chem.</source> <volume>275</volume> (<issue>6</issue>), <fpage>4007</fpage>&#x2013;<lpage>4012</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.6.4007</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Adewunmi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schek</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Flanagan</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Krebsbach</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering</article-title>. <source>Biomaterials</source> <volume>26</volume> (<issue>23</issue>), <fpage>4817</fpage>&#x2013;<lpage>4827</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2004.11.057</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>La</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Bhang</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>G. I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery</article-title>. <source>Tissue Eng. Part A</source> <volume>17</volume> (<issue>13-14</issue>), <fpage>1809</fpage>&#x2013;<lpage>1818</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2010.0540</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Um</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering</article-title>. <source>Biomaterials</source> <volume>33</volume> (<issue>29</issue>), <fpage>6952</fpage>&#x2013;<lpage>6964</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.06.067</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Articular cartilage reconstruction with TGF-&#x3b2;1-simulating self-assembling peptide hydrogel-based composite scaffold</article-title>. <source>Acta Biomater.</source> <volume>146</volume>, <fpage>94</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2022.05.012</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Demineralized bone matrix carriers and their clinical applications: An overview</article-title>. <source>Orthop. Surg.</source> <volume>11</volume> (<issue>5</issue>), <fpage>725</fpage>&#x2013;<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1111/os.12509</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mujeeb</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Probing cell&#x2013;matrix interactions in RGD-decorated macroporous poly (ethylene glycol) hydrogels for 3D chondrocyte culture</article-title>. <source>Biomed. Mater.</source> <volume>10</volume> (<issue>3</issue>), <fpage>035016</fpage>. <pub-id pub-id-type="doi">10.1088/1748-6041/10/3/035016</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The promotion of osteochondral repair by combined intra-articular injection of parathyroid hormone-related protein and implantation of a bi-layer collagen-silk scaffold</article-title>. <source>Biomaterials</source> <volume>34</volume> (<issue>25</issue>), <fpage>6046</fpage>&#x2013;<lpage>6057</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.04.055</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gupte</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>P. X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Injectable peptide decorated functional nanofibrous hollow microspheres to direct stem cell differentiation and tissue regeneration</article-title>. <source>Adv. Funct. Mater.</source> <volume>25</volume> (<issue>3</issue>), <fpage>350</fpage>&#x2013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1002/adfm.201402618</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Research progress on the hedgehog signalling pathway in regulating bone formation and homeostasis</article-title>. <source>Cell Prolif.</source> <volume>55</volume> (<issue>1</issue>), <fpage>e13162</fpage>. <pub-id pub-id-type="doi">10.1111/cpr.13162</pub-id>
</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Stem cell&#x2013;homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model</article-title>. <source>Sci. Adv.</source> <volume>8</volume> (<issue>13</issue>), <fpage>eabk0011</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abk0011</pub-id>
</citation>
</ref>
<ref id="B138">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zreiqat</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Akin</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Howlett</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Markovic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lateef</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Differentiation of human bone-derived cells grown on GRGDSP-peptide bound titanium surfacesThe Japanese Society for Biomaterials</article-title>. <source>J. Biomed. Mater. Res. Part A Official J. Soc. Biomaterialsand Aust. Soc. Biomaterials Korean Soc. Biomaterials</source> <volume>64</volume> (<issue>1</issue>), <fpage>105</fpage>&#x2013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.10376</pub-id>
</citation>
</ref>
</ref-list>
<sec id="s12">
<title>Glossary</title>
<def-list>
<def-item>
<term id="G1-fbioe.2023.1127949">FGF2:</term>
<def>
<p>fibroblast growth factor-2;</p>
</def>
</def-item>
<def-item>
<term id="G2-fbioe.2023.1127949">TGF-&#x3b2;:</term>
<def>
<p>transforming growth factor-&#x3b2;;</p>
</def>
</def-item>
<def-item>
<term id="G3-fbioe.2023.1127949">PDGF:</term>
<def>
<p>platelet-derived growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G4-fbioe.2023.1127949">HGF:</term>
<def>
<p>hematopoietic growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G5-fbioe.2023.1127949">VEGF:</term>
<def>
<p>vascular endothelial growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G6-fbioe.2023.1127949">OA:</term>
<def>
<p>Osteoarthritis;</p>
</def>
</def-item>
<def-item>
<term id="G7-fbioe.2023.1127949">RGD:</term>
<def>
<p>ARG-Gly-ASP;</p>
</def>
</def-item>
<def-item>
<term id="G8-fbioe.2023.1127949">TPO:</term>
<def>
<p>thrombopoietin;</p>
</def>
</def-item>
<def-item>
<term id="G9-fbioe.2023.1127949">TNF:</term>
<def>
<p>tumor necrosis factor;</p>
</def>
</def-item>
<def-item>
<term id="G10-fbioe.2023.1127949">BMSC:</term>
<def>
<p>bone marrow stem cell;</p>
</def>
</def-item>
<def-item>
<term id="G11-fbioe.2023.1127949">IGFBP:</term>
<def>
<p>insulin-like growth factors-binding protein;</p>
</def>
</def-item>
<def-item>
<term id="G12-fbioe.2023.1127949">IGF:</term>
<def>
<p>insulin-like growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G13-fbioe.2023.1127949">bFGF:</term>
<def>
<p>basic fibroblast growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G14-fbioe.2023.1127949">BMHP:</term>
<def>
<p>bone marrow homing peptide;</p>
</def>
</def-item>
<def-item>
<term id="G15-fbioe.2023.1127949">BMP:</term>
<def>
<p>bone morphogenetic protein;</p>
</def>
</def-item>
<def-item>
<term id="G16-fbioe.2023.1127949">N-cadherin:</term>
<def>
<p>Neurogenic cadherin;</p>
</def>
</def-item>
<def-item>
<term id="G17-fbioe.2023.1127949">HAV:</term>
<def>
<p>His-Ala-Val;</p>
</def>
</def-item>
<def-item>
<term id="G18-fbioe.2023.1127949">CM:</term>
<def>
<p>cytomodulin;</p>
</def>
</def-item>
<def-item>
<term id="G19-fbioe.2023.1127949">FNF-HMS:</term>
<def>
<p>functional nanofi brous hollow microspheres;</p>
</def>
</def-item>
<def-item>
<term id="G20-fbioe.2023.1127949">hMSC:</term>
<def>
<p>human mesenchymal stem cell;</p>
</def>
</def-item>
<def-item>
<term id="G21-fbioe.2023.1127949">hPLSC:</term>
<def>
<p>human periodontal ligament stem cell;</p>
</def>
</def-item>
<def-item>
<term id="G22-fbioe.2023.1127949">GAG:</term>
<def>
<p>glycosaminoglycan;</p>
</def>
</def-item>
<def-item>
<term id="G23-fbioe.2023.1127949">3D:</term>
<def>
<p>three-dimensional;</p>
</def>
</def-item>
<def-item>
<term id="G24-fbioe.2023.1127949">DCM:</term>
<def>
<p>decellularized cartilage matrix;</p>
</def>
</def-item>
<def-item>
<term id="G25-fbioe.2023.1127949">CT:</term>
<def>
<p>computed tomography;</p>
</def>
</def-item>
<def-item>
<term id="G26-fbioe.2023.1127949">HGP:</term>
<def>
<p>hydrogel particle;</p>
</def>
</def-item>
<def-item>
<term id="G27-fbioe.2023.1127949">ECM:</term>
<def>
<p>extracellular matrix;</p>
</def>
</def-item>
<def-item>
<term id="G28-fbioe.2023.1127949">PEG:</term>
<def>
<p>polyethylene glycol;</p>
</def>
</def-item>
<def-item>
<term id="G29-fbioe.2023.1127949">hPDC:</term>
<def>
<p>human periosteum-derived cell;</p>
</def>
</def-item>
<def-item>
<term id="G30-fbioe.2023.1127949">Au-NP:</term>
<def>
<p>gold nanoparticle;</p>
</def>
</def-item>
<def-item>
<term id="G31-fbioe.2023.1127949">PTHrP:</term>
<def>
<p>parathyroid hormone-associated protein;</p>
</def>
</def-item>
<def-item>
<term id="G32-fbioe.2023.1127949">ADSC:</term>
<def>
<p>adipose mesenchymal stem cell;</p>
</def>
</def-item>
<def-item>
<term id="G33-fbioe.2023.1127949">DBM:</term>
<def>
<p>demineralized bone matrix;</p>
</def>
</def-item>
<def-item>
<term id="G34-fbioe.2023.1127949">SMSCs:</term>
<def>
<p>synovial mesenchymal stem cells;</p>
</def>
</def-item>
<def-item>
<term id="G35-fbioe.2023.1127949">HA:</term>
<def>
<p>hyaluronic acid;</p>
</def>
</def-item>
<def-item>
<term id="G36-fbioe.2023.1127949">PCL:</term>
<def>
<p>polycaprolactone;</p>
</def>
</def-item>
<def-item>
<term id="G37-fbioe.2023.1127949">PLA:</term>
<def>
<p>polylactic acid;</p>
</def>
</def-item>
<def-item>
<term id="G38-fbioe.2023.1127949">PVA:</term>
<def>
<p>polyvinyl alcohol;</p>
</def>
</def-item>
<def-item>
<term id="G39-fbioe.2023.1127949">PEG:</term>
<def>
<p>polyethylene glycol;</p>
</def>
</def-item>
<def-item>
<term id="G40-fbioe.2023.1127949">PGA:</term>
<def>
<p>polyglycolic acid;</p>
</def>
</def-item>
<def-item>
<term id="G41-fbioe.2023.1127949">PEI:</term>
<def>
<p>polyethyleneimine;</p>
</def>
</def-item>
<def-item>
<term id="G42-fbioe.2023.1127949">FDA:</term>
<def>
<p>Food and Drug Administration;</p>
</def>
</def-item>
<def-item>
<term id="G43-fbioe.2023.1127949">PLGA:</term>
<def>
<p>Poly(lactic-co-glycolic acid);</p>
</def>
</def-item>
<def-item>
<term id="G44-fbioe.2023.1127949">TDN:</term>
<def>
<p>tetrahedral DNA nanostructure;</p>
</def>
</def-item>
<def-item>
<term id="G45-fbioe.2023.1127949">PDA:</term>
<def>
<p>polydopamine;</p>
</def>
</def-item>
<def-item>
<term id="G46-fbioe.2023.1127949">NGF:</term>
<def>
<p>nerve growth factor;</p>
</def>
</def-item>
<def-item>
<term id="G47-fbioe.2023.1127949">NSC:</term>
<def>
<p>neural stem cell.</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>